Frequencies for first 10,000 rows of pt variable in reac2004q3 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 15 0.15 0.15 ABDOMINAL ABSCESS | 1 0.01 0.16 ABDOMINAL ADHESIONS | 2 0.02 0.18 ABDOMINAL AORTIC BRUIT | 1 0.01 0.19 ABDOMINAL DISCOMFORT | 12 0.12 0.31 ABDOMINAL DISTENSION | 29 0.29 0.60 ABDOMINAL HAEMATOMA | 1 0.01 0.61 ABDOMINAL HERNIA | 1 0.01 0.62 ABDOMINAL MASS | 1 0.01 0.63 ABDOMINAL OPERATION | 2 0.02 0.65 ABDOMINAL PAIN | 46 0.46 1.11 ABDOMINAL PAIN LOWER | 6 0.06 1.17 ABDOMINAL PAIN UPPER | 29 0.29 1.46 ABDOMINAL SEPSIS | 1 0.01 1.47 ABDOMINAL STRANGULATED HERNIA | 1 0.01 1.48 ABDOMINAL TENDERNESS | 3 0.03 1.51 ABDOMINAL WALL ABSCESS | 1 0.01 1.52 ABNORMAL BEHAVIOUR | 13 0.13 1.65 ABNORMAL CLOTTING FACTOR | 1 0.01 1.66 ABNORMAL DREAMS | 8 0.08 1.74 ABNORMAL FAECES | 1 0.01 1.75 ABNORMAL SENSATION IN EYE | 1 0.01 1.76 ABORTION INDUCED | 4 0.04 1.80 ABORTION SPONTANEOUS | 11 0.11 1.91 ABSCESS | 3 0.03 1.94 ABSCESS INTESTINAL | 3 0.03 1.97 ABULIA | 1 0.01 1.98 ACALCULIA | 1 0.01 1.99 ACCIDENT | 7 0.07 2.06 ACCIDENTAL EXPOSURE | 2 0.02 2.08 ACCIDENTAL NEEDLE STICK | 1 0.01 2.09 ACCIDENTAL OVERDOSE | 8 0.08 2.17 ACIDOSIS | 2 0.02 2.19 ACNE PUSTULAR | 1 0.01 2.20 ACQUIRED MACROCEPHALY | 1 0.01 2.21 ACQUIRED METHAEMOGLOBINAEMIA | 3 0.03 2.24 ACQUIRED NIGHT BLINDNESS | 1 0.01 2.25 ACQUIRED OESOPHAGEAL WEB | 1 0.01 2.26 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 2 0.02 2.28 ACTIVITIES OF DAILY LIVING IMPAIRED | 1 0.01 2.29 ACUTE ABDOMEN | 2 0.02 2.31 ACUTE CORONARY SYNDROME | 2 0.02 2.33 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 1 0.01 2.34 ACUTE LEUKAEMIA | 1 0.01 2.35 ACUTE MYELOID LEUKAEMIA | 2 0.02 2.37 ACUTE MYOCARDIAL INFARCTION | 14 0.14 2.51 ACUTE PRERENAL FAILURE | 2 0.02 2.53 ACUTE PSYCHOSIS | 1 0.01 2.54 ACUTE PULMONARY OEDEMA | 2 0.02 2.56 ACUTE RESPIRATORY DISTRESS SYNDROME | 7 0.07 2.63 ACUTE RESPIRATORY FAILURE | 2 0.02 2.65 ADENOCARCINOMA | 1 0.01 2.66 ADENOMA BENIGN | 1 0.01 2.67 ADENOMYOSIS | 1 0.01 2.68 ADJUSTMENT DISORDER | 1 0.01 2.69 ADNEXA UTERI MASS | 1 0.01 2.70 ADRENAL CORTEX NECROSIS | 1 0.01 2.71 ADRENAL MASS | 1 0.01 2.72 ADRENOCORTICAL INSUFFICIENCY ACUTE | 1 0.01 2.73 ADVERSE DRUG REACTION | 4 0.04 2.77 ADVERSE EVENT | 5 0.05 2.82 AFFECT LABILITY | 1 0.01 2.83 AGE INDETERMINATE MYOCARDIAL INFARCTION | 1 0.01 2.84 AGEUSIA | 6 0.06 2.90 AGGRESSION | 17 0.17 3.07 AGITATION | 19 0.19 3.26 AGORAPHOBIA | 1 0.01 3.27 AGRANULOCYTOSIS | 7 0.07 3.34 AKATHISIA | 3 0.03 3.37 ALANINE AMINOTRANSFERASE | 1 0.01 3.38 ALANINE AMINOTRANSFERASE INCREASED | 46 0.46 3.84 ALCOHOL POISONING | 1 0.01 3.85 ALCOHOL USE | 4 0.04 3.89 ALLERGIC GRANULOMATOUS ANGIITIS | 5 0.05 3.94 ALLODYNIA | 1 0.01 3.95 ALOPECIA | 15 0.15 4.10 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECT.. | 1 0.01 4.11 ALVEOLITIS | 1 0.01 4.12 AMENORRHOEA | 2 0.02 4.14 AMNESIA | 11 0.11 4.25 AMYOTROPHY | 1 0.01 4.26 ANAEMIA | 33 0.33 4.59 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 2 0.02 4.61 ANAEMIA MACROCYTIC | 1 0.01 4.62 ANAEMIA POSTOPERATIVE | 1 0.01 4.63 ANAL FISTULA | 1 0.01 4.64 ANAPHYLACTIC REACTION | 8 0.08 4.72 ANAPHYLACTIC SHOCK | 2 0.02 4.74 ANAPHYLACTOID REACTION | 1 0.01 4.75 ANAPLASTIC LARGE CELL LYMPHOMA T- AND.. | 1 0.01 4.76 ANEURYSM | 4 0.04 4.80 ANGER | 8 0.08 4.88 ANGINA PECTORIS | 12 0.12 5.00 ANGINA UNSTABLE | 5 0.05 5.05 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA | 1 0.01 5.06 ANGIONEUROTIC OEDEMA | 10 0.10 5.16 ANGIOPATHY | 2 0.02 5.18 ANGIOTENSIN CONVERTING ENZYME INCREASED | 1 0.01 5.19 ANHEDONIA | 3 0.03 5.22 ANKLE FRACTURE | 2 0.02 5.24 ANORECTAL DISORDER | 1 0.01 5.25 ANOREXIA | 25 0.25 5.50 ANOSMIA | 3 0.03 5.53 ANOXIC ENCEPHALOPATHY | 1 0.01 5.54 ANTEPARTUM HAEMORRHAGE | 1 0.01 5.55 ANTI-THYROID ANTIBODY POSITIVE | 1 0.01 5.56 ANTIBODY TEST POSITIVE | 3 0.03 5.59 ANTICONVULSANT DRUG LEVEL DECREASED | 1 0.01 5.60 ANTICONVULSANT DRUG LEVEL INCREASED | 2 0.02 5.62 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY P.. | 1 0.01 5.63 ANTINUCLEAR ANTIBODY POSITIVE | 3 0.03 5.66 ANTITHROMBIN III DECREASED | 1 0.01 5.67 ANURIA | 4 0.04 5.71 ANXIETY | 42 0.42 6.13 ANXIETY DISORDER | 2 0.02 6.15 AORTIC ANEURYSM | 1 0.01 6.16 AORTIC ATHEROSCLEROSIS | 3 0.03 6.19 AORTIC CALCIFICATION | 2 0.02 6.21 AORTIC DILATATION | 2 0.02 6.23 AORTIC RUPTURE | 1 0.01 6.24 AORTIC STENOSIS | 2 0.02 6.26 AORTIC THROMBOSIS | 1 0.01 6.27 AORTIC VALVE INCOMPETENCE | 5 0.05 6.32 AORTIC VALVE SCLEROSIS | 2 0.02 6.34 AORTIC VALVE STENOSIS | 1 0.01 6.35 APALLIC SYNDROME | 1 0.01 6.36 APATHY | 2 0.02 6.38 APHASIA | 7 0.07 6.45 APHONIA | 1 0.01 6.46 APLASIA PURE RED CELL | 2 0.02 6.48 APNOEA | 2 0.02 6.50 APPENDICECTOMY | 1 0.01 6.51 APPENDICITIS PERFORATED | 1 0.01 6.52 APPETITE DISORDER | 2 0.02 6.54 APPLICATION SITE BURNING | 1 0.01 6.55 APPLICATION SITE DERMATITIS | 1 0.01 6.56 APPLICATION SITE ERYTHEMA | 3 0.03 6.59 APPLICATION SITE IRRITATION | 1 0.01 6.60 APPLICATION SITE PAPULES | 1 0.01 6.61 APPLICATION SITE PRURITUS | 2 0.02 6.63 APPLICATION SITE REACTION | 8 0.08 6.71 APPLICATION SITE SCAR | 1 0.01 6.72 APPLICATION SITE URTICARIA | 1 0.01 6.73 APPLICATION SITE VESICLES | 1 0.01 6.74 AREFLEXIA | 1 0.01 6.75 ARRHYTHMIA | 19 0.19 6.94 ARRHYTHMIA SUPRAVENTRICULAR | 4 0.04 6.98 ARTERIAL DISORDER | 1 0.01 6.99 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 7.00 ARTERIAL RUPTURE | 1 0.01 7.01 ARTERIAL STENOSIS | 2 0.02 7.03 ARTERIAL THROMBOSIS | 1 0.01 7.04 ARTERIAL THROMBOSIS LIMB | 1 0.01 7.05 ARTERIOSPASM CORONARY | 2 0.02 7.07 ARTERITIS | 1 0.01 7.08 ARTERY DISSECTION | 1 0.01 7.09 ARTHRALGIA | 70 0.70 7.79 ARTHRITIS | 12 0.12 7.91 ARTHROPATHY | 7 0.07 7.98 ASCITES | 8 0.08 8.06 ASEPTIC NECROSIS BONE | 1 0.01 8.07 ASPARTATE AMINOTRANSFERASE INCREASED | 51 0.51 8.58 ASPERGILLOSIS | 2 0.02 8.60 ASPHYXIA | 1 0.01 8.61 ASPIRATION | 3 0.03 8.64 ASTERIXIS | 1 0.01 8.65 ASTHENIA | 100 1.00 9.65 ASTHMA | 12 0.12 9.77 ATAXIA | 3 0.03 9.80 ATELECTASIS | 8 0.08 9.88 ATHEROSCLEROSIS | 5 0.05 9.93 ATRIAL FIBRILLATION | 24 0.24 10.17 ATRIOVENTRICULAR BLOCK | 4 0.04 10.21 ATRIOVENTRICULAR BLOCK COMPLETE | 2 0.02 10.23 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 4 0.04 10.27 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 1 0.01 10.28 ATTENTION-SEEKING BEHAVIOUR | 1 0.01 10.29 ATYPICAL MYCOBACTERIAL LYMPHADENITIS | 1 0.01 10.30 AUTOIMMUNE DISORDER | 1 0.01 10.31 AUTOIMMUNE HEPATITIS | 1 0.01 10.32 AZOTAEMIA | 1 0.01 10.33 BACK DISORDER | 2 0.02 10.35 BACK INJURY | 5 0.05 10.40 BACK PAIN | 39 0.39 10.79 BACTERAEMIA | 2 0.02 10.81 BACTERIA URINE IDENTIFIED | 1 0.01 10.82 BACTERIAL CULTURE POSITIVE | 1 0.01 10.83 BACTERIAL INFECTION | 4 0.04 10.87 BACTERIAL SEPSIS | 2 0.02 10.89 BALANCE DISORDER | 10 0.10 10.99 BASAL CELL CARCINOMA | 1 0.01 11.00 BASEDOW'S DISEASE | 1 0.01 11.01 BEDRIDDEN | 2 0.02 11.03 BELLIGERENCE | 2 0.02 11.05 BENIGN BONE NEOPLASM | 1 0.01 11.06 BENIGN BREAST NEOPLASM | 1 0.01 11.07 BENIGN INTRACRANIAL HYPERTENSION | 1 0.01 11.08 BENIGN PROSTATIC HYPERPLASIA | 3 0.03 11.11 BETA-N-ACETYL-D-GLUCOSAMINIDASE INCRE.. | 1 0.01 11.12 BEZOAR | 1 0.01 11.13 BILATERAL HYDRONEPHROSIS | 1 0.01 11.14 BILE DUCT OBSTRUCTION | 4 0.04 11.18 BILE DUCT STENOSIS | 1 0.01 11.19 BILIARY ANASTOMOSIS COMPLICATION | 1 0.01 11.20 BILIARY DILATATION | 1 0.01 11.21 BILIARY DYSKINESIA | 1 0.01 11.22 BILIARY NEOPLASM | 2 0.02 11.24 BILIRUBIN CONJUGATED INCREASED | 1 0.01 11.25 BIOPSY BONE MARROW ABNORMAL | 1 0.01 11.26 BIPOLAR DISORDER | 2 0.02 11.28 BIPOLAR I DISORDER | 2 0.02 11.30 BLADDER CANCER | 3 0.03 11.33 BLADDER DISORDER | 3 0.03 11.36 BLADDER DISTENSION | 2 0.02 11.38 BLADDER NEOPLASM | 1 0.01 11.39 BLADDER OBSTRUCTION | 2 0.02 11.41 BLADDER SPASM | 2 0.02 11.43 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA | 1 0.01 11.44 BLEEDING TIME PROLONGED | 2 0.02 11.46 BLEPHARITIS | 1 0.01 11.47 BLINDNESS | 6 0.06 11.53 BLINDNESS TRANSIENT | 5 0.05 11.58 BLINDNESS UNILATERAL | 5 0.05 11.63 BLISTER | 5 0.05 11.68 BLOOD ALBUMIN DECREASED | 5 0.05 11.73 BLOOD ALBUMIN INCREASED | 1 0.01 11.74 BLOOD ALKALINE PHOSPHATASE INCREASED | 21 0.21 11.95 BLOOD AMYLASE INCREASED | 6 0.06 12.01 BLOOD BICARBONATE INCREASED | 1 0.01 12.02 BLOOD BILIRUBIN INCREASED | 21 0.21 12.23 BLOOD BLISTER | 1 0.01 12.24 BLOOD CALCIUM DECREASED | 3 0.03 12.27 BLOOD CHOLESTEROL DECREASED | 2 0.02 12.29 BLOOD CHOLESTEROL INCREASED | 21 0.21 12.50 BLOOD CHOLINESTERASE INCREASED | 1 0.01 12.51 BLOOD CORTISOL INCREASED | 1 0.01 12.52 BLOOD CREATINE DECREASED | 1 0.01 12.53 BLOOD CREATINE INCREASED | 2 0.02 12.55 BLOOD CREATINE PHOSPHOKINASE INCREASED | 36 0.36 12.91 BLOOD CREATINE PHOSPHOKINASE MB | 1 0.01 12.92 BLOOD CREATINE PHOSPHOKINASE MB INCRE.. | 1 0.01 12.93 BLOOD CREATININE INCREASED | 33 0.33 13.26 BLOOD CULTURE POSITIVE | 3 0.03 13.29 BLOOD DISORDER | 3 0.03 13.32 BLOOD FOLATE DECREASED | 1 0.01 13.33 BLOOD GLUCOSE ABNORMAL | 2 0.02 13.35 BLOOD GLUCOSE DECREASED | 2 0.02 13.37 BLOOD GLUCOSE FLUCTUATION | 4 0.04 13.41 BLOOD GLUCOSE INCREASED | 33 0.33 13.74 BLOOD HOMOCYSTEINE INCREASED | 1 0.01 13.75 BLOOD IMMUNOGLOBULIN E INCREASED | 1 0.01 13.76 BLOOD IRON ABNORMAL | 1 0.01 13.77 BLOOD IRON INCREASED | 1 0.01 13.78 BLOOD LACTATE DEHYDROGENASE INCREASED | 11 0.11 13.89 BLOOD LACTIC ACID INCREASED | 1 0.01 13.90 BLOOD MAGNESIUM ABNORMAL | 2 0.02 13.92 BLOOD MAGNESIUM DECREASED | 5 0.05 13.97 BLOOD MAGNESIUM INCREASED | 2 0.02 13.99 BLOOD PARATHYROID HORMONE INCREASED | 1 0.01 14.00 BLOOD PH DECREASED | 2 0.02 14.02 BLOOD PHOSPHORUS DECREASED | 1 0.01 14.03 BLOOD POTASSIUM ABNORMAL | 1 0.01 14.04 BLOOD POTASSIUM DECREASED | 9 0.09 14.13 BLOOD POTASSIUM INCREASED | 4 0.04 14.17 BLOOD PRESSURE ABNORMAL | 1 0.01 14.18 BLOOD PRESSURE DECREASED | 25 0.25 14.43 BLOOD PRESSURE DIASTOLIC DECREASED | 3 0.03 14.46 BLOOD PRESSURE DIASTOLIC INCREASED | 2 0.02 14.48 BLOOD PRESSURE FLUCTUATION | 2 0.02 14.50 BLOOD PRESSURE IMMEASURABLE | 2 0.02 14.52 BLOOD PRESSURE INADEQUATELY CONTROLLED | 3 0.03 14.55 BLOOD PRESSURE INCREASED | 36 0.36 14.91 BLOOD PRESSURE ORTHOSTATIC | 1 0.01 14.92 BLOOD PRESSURE SYSTOLIC INCREASED | 3 0.03 14.95 BLOOD SODIUM DECREASED | 1 0.01 14.96 BLOOD THYROID STIMULATING HORMONE INC.. | 2 0.02 14.98 BLOOD TRIGLYCERIDES INCREASED | 29 0.29 15.27 BLOOD UREA DECREASED | 1 0.01 15.28 BLOOD UREA INCREASED | 11 0.11 15.39 BLOOD URIC ACID INCREASED | 6 0.06 15.45 BLOOD URINE | 4 0.04 15.49 BLOOD URINE PRESENT | 2 0.02 15.51 BLOOD VISCOSITY INCREASED | 1 0.01 15.52 BLUNTED AFFECT | 1 0.01 15.53 BODY HEIGHT DECREASED | 5 0.05 15.58 BODY TEMPERATURE DECREASED | 2 0.02 15.60 BODY TEMPERATURE INCREASED | 6 0.06 15.66 BODY TINEA | 1 0.01 15.67 BONE DENSITY DECREASED | 4 0.04 15.71 BONE DISORDER | 1 0.01 15.72 BONE EROSION | 1 0.01 15.73 BONE MARROW DEPRESSION | 10 0.10 15.83 BONE MARROW DISORDER | 1 0.01 15.84 BONE PAIN | 5 0.05 15.89 BONE SCAN ABNORMAL | 1 0.01 15.90 BOWEL SOUNDS ABNORMAL | 1 0.01 15.91 BRADYCARDIA | 15 0.15 16.06 BRADYPHRENIA | 2 0.02 16.08 BRADYPNOEA | 1 0.01 16.09 BRAIN DAMAGE | 3 0.03 16.12 BRAIN HERNIATION | 2 0.02 16.14 BRAIN MALFORMATION | 1 0.01 16.15 BRAIN NATRIURETIC PEPTIDE INCREASED | 2 0.02 16.17 BRAIN NEOPLASM | 1 0.01 16.18 BRAIN OEDEMA | 2 0.02 16.20 BRAIN STEM INFARCTION | 2 0.02 16.22 BRAIN STEM SYNDROME | 2 0.02 16.24 BRAIN TUMOUR OPERATION | 1 0.01 16.25 BREAST ABSCESS | 1 0.01 16.26 BREAST CANCER | 6 0.06 16.32 BREAST CANCER FEMALE | 10 0.10 16.42 BREAST CANCER METASTATIC | 1 0.01 16.43 BREAST CANCER STAGE IV | 1 0.01 16.44 BREAST MASS | 1 0.01 16.45 BREAST NEOPLASM | 1 0.01 16.46 BREAST OEDEMA | 1 0.01 16.47 BREAST PAIN | 3 0.03 16.50 BREAST SWELLING | 1 0.01 16.51 BREAST TENDERNESS | 2 0.02 16.53 BREATH SOUNDS DECREASED | 2 0.02 16.55 BRONCHIECTASIS | 1 0.01 16.56 BRONCHITIS | 12 0.12 16.68 BRONCHITIS ACUTE | 1 0.01 16.69 BRONCHOPNEUMONIA | 4 0.04 16.73 BRONCHOPULMONARY ASPERGILLOSIS | 3 0.03 16.76 BRONCHOSPASM | 1 0.01 16.77 BRUCELLA SEROLOGY POSITIVE | 1 0.01 16.78 BRUXISM | 1 0.01 16.79 BULIMIA NERVOSA | 1 0.01 16.80 BUNDLE BRANCH BLOCK LEFT | 3 0.03 16.83 BUNDLE BRANCH BLOCK RIGHT | 3 0.03 16.86 BURNING SENSATION | 13 0.13 16.99 BURSA REMOVAL | 1 0.01 17.00 BURSITIS | 4 0.04 17.04 BUTTOCK PAIN | 2 0.02 17.06 C-REACTIVE PROTEIN INCREASED | 16 0.16 17.22 CACHEXIA | 1 0.01 17.23 CAECITIS | 1 0.01 17.24 CAESAREAN SECTION | 3 0.03 17.27 CANDIDIASIS | 2 0.02 17.29 CARCINOMA | 1 0.01 17.30 CARDIAC ABLATION | 1 0.01 17.31 CARDIAC ANEURYSM | 1 0.01 17.32 CARDIAC ARREST | 20 0.20 17.52 CARDIAC DISORDER | 11 0.11 17.63 CARDIAC FAILURE | 9 0.09 17.72 CARDIAC FAILURE CONGESTIVE | 27 0.27 17.99 CARDIAC FAILURE HIGH OUTPUT | 1 0.01 18.00 CARDIAC FLUTTER | 3 0.03 18.03 CARDIAC MURMUR | 7 0.07 18.10 CARDIAC MURMUR FUNCTIONAL | 1 0.01 18.11 CARDIAC OPERATION | 2 0.02 18.13 CARDIAC PACEMAKER INSERTION | 1 0.01 18.14 CARDIAC PROCEDURE COMPLICATION | 1 0.01 18.15 CARDIAC STRESS TEST | 1 0.01 18.16 CARDIAC STRESS TEST ABNORMAL | 3 0.03 18.19 CARDIAC VALVE DISEASE | 3 0.03 18.22 CARDIO-RESPIRATORY ARREST | 10 0.10 18.32 CARDIOGENIC SHOCK | 3 0.03 18.35 CARDIOMEGALY | 13 0.13 18.48 CARDIOMYOPATHY | 8 0.08 18.56 CARDIOMYOPATHY ACUTE | 1 0.01 18.57 CARDIOPULMONARY FAILURE | 1 0.01 18.58 CARDIOVASCULAR DISORDER | 8 0.08 18.66 CAROTID ARTERY DISEASE | 1 0.01 18.67 CAROTID ARTERY OCCLUSION | 2 0.02 18.69 CAROTID ARTERY STENOSIS | 6 0.06 18.75 CAROTID BRUIT | 1 0.01 18.76 CARPAL TUNNEL SYNDROME | 5 0.05 18.81 CARTILAGE INJURY | 2 0.02 18.83 CATARACT | 3 0.03 18.86 CATARACT OPERATION | 1 0.01 18.87 CATHETER RELATED COMPLICATION | 2 0.02 18.89 CATHETER RELATED INFECTION | 2 0.02 18.91 CATHETER SITE HAEMORRHAGE | 1 0.01 18.92 CATHETER SITE INFECTION | 1 0.01 18.93 CATHETER SITE RELATED REACTION | 1 0.01 18.94 CATHETERISATION CARDIAC | 1 0.01 18.95 CAUSTIC INJURY | 9 0.09 19.04 CD4 LYMPHOCYTES DECREASED | 1 0.01 19.05 CELLULITIS | 11 0.11 19.16 CEREBELLAR INFARCTION | 2 0.02 19.18 CEREBELLAR SYNDROME | 1 0.01 19.19 CEREBRAL ARTERITIS | 2 0.02 19.21 CEREBRAL ARTERY EMBOLISM | 1 0.01 19.22 CEREBRAL ARTERY OCCLUSION | 1 0.01 19.23 CEREBRAL ATHEROSCLEROSIS | 2 0.02 19.25 CEREBRAL CYST | 1 0.01 19.26 CEREBRAL HAEMORRHAGE | 10 0.10 19.36 CEREBRAL INFARCTION | 14 0.14 19.50 CEREBRAL ISCHAEMIA | 4 0.04 19.54 CEREBRAL PALSY | 1 0.01 19.55 CEREBROVASCULAR ACCIDENT | 29 0.29 19.84 CEREBROVASCULAR DISORDER | 2 0.02 19.86 CERVIX CARCINOMA | 1 0.01 19.87 CHANGE OF BOWEL HABIT | 1 0.01 19.88 CHEILITIS | 6 0.06 19.94 CHEST DISCOMFORT | 16 0.16 20.10 CHEST PAIN | 62 0.62 20.72 CHEST WALL PAIN | 4 0.04 20.76 CHEST X-RAY ABNORMAL | 2 0.02 20.78 CHILLS | 26 0.26 21.04 CHLOROPSIA | 1 0.01 21.05 CHOKING | 5 0.05 21.10 CHOLANGITIS | 1 0.01 21.11 CHOLANGITIS ACUTE | 1 0.01 21.12 CHOLECYSTECTOMY | 1 0.01 21.13 CHOLECYSTITIS | 4 0.04 21.17 CHOLECYSTITIS CHRONIC | 1 0.01 21.18 CHOLELITHIASIS | 9 0.09 21.27 CHOLESTASIS | 5 0.05 21.32 CHONDROPATHY | 1 0.01 21.33 CHONDROSARCOMA | 1 0.01 21.34 CHOROIDAL NEOVASCULARISATION | 1 0.01 21.35 CHROMATURIA | 21 0.21 21.56 CHRONIC FATIGUE SYNDROME | 4 0.04 21.60 CHRONIC HEPATITIS | 1 0.01 21.61 CHRONIC LYMPHOCYTIC LEUKAEMIA | 1 0.01 21.62 CHRONIC MYELOID LEUKAEMIA | 1 0.01 21.63 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE | 9 0.09 21.72 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE E.. | 4 0.04 21.76 CILIARY MUSCLE SPASM | 1 0.01 21.77 CIRCULATORY COLLAPSE | 11 0.11 21.88 CLAVICLE FRACTURE | 1 0.01 21.89 CLOSTRIDIUM COLITIS | 3 0.03 21.92 COAGULOPATHY | 7 0.07 21.99 COGNITIVE DISORDER | 3 0.03 22.02 COLD SWEAT | 7 0.07 22.09 COLITIS | 7 0.07 22.16 COLITIS ISCHAEMIC | 2 0.02 22.18 COLITIS ULCERATIVE | 3 0.03 22.21 COLLAPSE OF LUNG | 1 0.01 22.22 COLON CANCER | 2 0.02 22.24 COLONIC HAEMORRHAGE | 1 0.01 22.25 COLONIC POLYP | 1 0.01 22.26 COLONIC PSEUDO-OBSTRUCTION | 2 0.02 22.28 COLONOSCOPY | 1 0.01 22.29 COLOSTOMY | 1 0.01 22.30 COLOUR VISION TESTS ABNORMAL | 1 0.01 22.31 COMA | 20 0.20 22.51 COMMUNICATION DISORDER | 1 0.01 22.52 COMPLEMENT FACTOR C1 DECREASED | 1 0.01 22.53 COMPLETED SUICIDE | 9 0.09 22.62 COMPLEX PARTIAL SEIZURES | 1 0.01 22.63 COMPLICATION OF PREGNANCY | 1 0.01 22.64 COMPLICATIONS OF MATERNAL EXPOSURE TO.. | 4 0.04 22.68 COMPLICATIONS OF TRANSPLANT SURGERY | 1 0.01 22.69 COMPULSIONS | 1 0.01 22.70 COMPUTERISED TOMOGRAM ABDOMEN ABNORMAL | 1 0.01 22.71 COMPUTERISED TOMOGRAM ABNORMAL | 4 0.04 22.75 CONCUSSION | 2 0.02 22.77 CONDITION AGGRAVATED | 40 0.40 23.17 CONFUSIONAL STATE | 31 0.31 23.48 CONGENITAL ANOMALY | 5 0.05 23.53 CONGENITAL ATRIAL SEPTAL DEFECT | 1 0.01 23.54 CONGENITAL BRAIN DAMAGE | 1 0.01 23.55 CONGENITAL CENTRAL NERVOUS SYSTEM ANO.. | 1 0.01 23.56 CONGENITAL HYPOTHYROIDISM | 2 0.02 23.58 CONGENITAL MUSCULOSKELETAL ANOMALY | 1 0.01 23.59 CONGENITAL THROMBOCYTE DISORDER | 1 0.01 23.60 CONGENITAL VENTRICULAR SEPTAL DEFECT | 1 0.01 23.61 CONGESTIVE CARDIOMYOPATHY | 1 0.01 23.62 CONJUNCTIVAL HAEMORRHAGE | 1 0.01 23.63 CONJUNCTIVAL HYPERAEMIA | 2 0.02 23.65 CONJUNCTIVITIS | 2 0.02 23.67 CONJUNCTIVITIS ALLERGIC | 1 0.01 23.68 CONNECTIVE TISSUE INFLAMMATION | 1 0.01 23.69 CONSTIPATION | 44 0.44 24.13 CONTACT LENS COMPLICATION | 1 0.01 24.14 CONTRAST MEDIA REACTION | 1 0.01 24.15 CONTUSION | 18 0.18 24.33 CONVERSION DISORDER | 1 0.01 24.34 CONVULSION | 40 0.40 24.74 CONVULSIVE THRESHOLD LOWERED | 4 0.04 24.78 COOMBS DIRECT TEST POSITIVE | 1 0.01 24.79 COOMBS TEST POSITIVE | 1 0.01 24.80 COORDINATION ABNORMAL | 1 0.01 24.81 COR PULMONALE | 1 0.01 24.82 CORNEAL DEPOSITS | 1 0.01 24.83 CORNEAL TRANSPLANT | 1 0.01 24.84 CORONARY ARTERY ATHEROSCLEROSIS | 9 0.09 24.93 CORONARY ARTERY DISEASE | 19 0.19 25.12 CORONARY ARTERY DISSECTION | 1 0.01 25.13 CORONARY ARTERY INSUFFICIENCY | 1 0.01 25.14 CORONARY ARTERY OCCLUSION | 6 0.06 25.20 CORONARY ARTERY REOCCLUSION | 1 0.01 25.21 CORONARY ARTERY RESTENOSIS | 2 0.02 25.23 CORONARY ARTERY STENOSIS | 8 0.08 25.31 CORONARY ARTERY THROMBOSIS | 1 0.01 25.32 CORONARY BYPASS THROMBOSIS | 1 0.01 25.33 CORONARY OSTIAL STENOSIS | 1 0.01 25.34 COSTOCHONDRITIS | 1 0.01 25.35 COUGH | 38 0.38 25.73 CRACKLES LUNG | 1 0.01 25.74 CREATINE PHOSPHOKINASE DECREASED | 1 0.01 25.75 CREATININE RENAL CLEARANCE DECREASED | 1 0.01 25.76 CROHN'S DISEASE | 2 0.02 25.78 CRYING | 5 0.05 25.83 CRYPTOGENIC ORGANIZING PNEUMONIA | 1 0.01 25.84 CULTURE URINE POSITIVE | 1 0.01 25.85 CUTANEOUS LUPUS ERYTHEMATOSUS | 1 0.01 25.86 CUTANEOUS VASCULITIS | 2 0.02 25.88 CYANOSIS | 6 0.06 25.94 CYSTOCELE | 1 0.01 25.95 CYTOLYTIC HEPATITIS | 5 0.05 26.00 CYTOMEGALOVIRUS GASTRITIS | 1 0.01 26.01 CYTOMEGALOVIRUS INFECTION | 6 0.06 26.07 CYTOMEGALOVIRUS OESOPHAGITIS | 1 0.01 26.08 CYTOMEGALOVIRUS VIRAEMIA | 1 0.01 26.09 DEAFNESS | 9 0.09 26.18 DEAFNESS BILATERAL | 1 0.01 26.19 DEAFNESS NEUROSENSORY | 2 0.02 26.21 DEATH | 44 0.44 26.65 DEATH NEONATAL | 4 0.04 26.69 DECEREBRATION | 2 0.02 26.71 DECREASED ACTIVITY | 1 0.01 26.72 DECREASED APPETITE | 6 0.06 26.78 DEEP VEIN THROMBOSIS | 19 0.19 26.97 DEHYDRATION | 27 0.27 27.24 DELIRIUM | 12 0.12 27.36 DELUSION | 2 0.02 27.38 DELUSIONAL PERCEPTION | 1 0.01 27.39 DEMENTIA | 5 0.05 27.44 DEMENTIA ALZHEIMER'S TYPE | 2 0.02 27.46 DENTAL CARIES | 1 0.01 27.47 DEPENDENCE | 1 0.01 27.48 DEPRESSED LEVEL OF CONSCIOUSNESS | 30 0.30 27.78 DEPRESSION | 53 0.53 28.31 DEREALISATION | 2 0.02 28.33 DERMATITIS | 4 0.04 28.37 DERMATITIS ACNEIFORM | 1 0.01 28.38 DERMATITIS ALLERGIC | 1 0.01 28.39 DERMATITIS CONTACT | 1 0.01 28.40 DERMATITIS EXFOLIATIVE | 3 0.03 28.43 DERMOGRAPHISM | 1 0.01 28.44 DETOXIFICATION | 1 0.01 28.45 DEVELOPMENTAL DELAY | 2 0.02 28.47 DEVICE FAILURE | 1 0.01 28.48 DIABETES MELLITUS | 10 0.10 28.58 DIABETES MELLITUS INADEQUATE CONTROL | 6 0.06 28.64 DIABETES MELLITUS INSULIN-DEPENDENT | 3 0.03 28.67 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 4 0.04 28.71 DIABETIC FOOT | 1 0.01 28.72 DIABETIC GANGRENE | 1 0.01 28.73 DIABETIC NEUROPATHY | 2 0.02 28.75 DIABETIC RETINOPATHY | 1 0.01 28.76 DIALYSIS | 8 0.08 28.84 DIAPHRAGMATIC PARALYSIS | 1 0.01 28.85 DIARRHOEA | 72 0.72 29.57 DIARRHOEA HAEMORRHAGIC | 2 0.02 29.59 DIASTOLIC DYSFUNCTION | 3 0.03 29.62 DIFFICULTY IN WALKING | 21 0.21 29.83 DIHYDROPYRIMIDINE DEHYDROGENASE DEFIC.. | 1 0.01 29.84 DILATATION ATRIAL | 4 0.04 29.88 DILATATION VENTRICULAR | 1 0.01 29.89 DIPLEGIA | 2 0.02 29.91 DIPLOPIA | 7 0.07 29.98 DISABILITY | 2 0.02 30.00 DISCOMFORT | 5 0.05 30.05 DISEASE PROGRESSION | 9 0.09 30.14 DISEASE RECURRENCE | 4 0.04 30.18 DISINHIBITION | 1 0.01 30.19 DISORDER OF GLOBE | 1 0.01 30.20 DISORIENTATION | 11 0.11 30.31 DISSEMINATED INTRAVASCULAR COAGULATION | 5 0.05 30.36 DISSOCIATION | 2 0.02 30.38 DISTURBANCE IN ATTENTION | 7 0.07 30.45 DIVERTICULITIS | 12 0.12 30.57 DIVERTICULITIS INTESTINAL HAEMORRHAGIC | 1 0.01 30.58 DIVERTICULUM | 10 0.10 30.68 DIVERTICULUM INTESTINAL | 1 0.01 30.69 DIZZINESS | 86 0.86 31.55 DIZZINESS POSTURAL | 2 0.02 31.57 DOUBLE VESSEL BYPASS GRAFT | 1 0.01 31.58 DROOLING | 1 0.01 31.59 DRUG ABUSER | 5 0.05 31.64 DRUG DEPENDENCE | 6 0.06 31.70 DRUG EFFECT DECREASED | 10 0.10 31.80 DRUG EFFECT INCREASED | 2 0.02 31.82 DRUG ERUPTION | 6 0.06 31.88 DRUG EXPOSURE DURING PREGNANCY | 57 0.57 32.45 DRUG EXPOSURE VIA BREAST MILK | 3 0.03 32.48 DRUG HYPERSENSITIVITY | 20 0.20 32.68 DRUG INEFFECTIVE | 49 0.49 33.17 DRUG INTERACTION | 54 0.54 33.71 DRUG INTERACTION POTENTIATION | 3 0.03 33.74 DRUG LEVEL BELOW THERAPEUTIC | 1 0.01 33.75 DRUG LEVEL DECREASED | 3 0.03 33.78 DRUG LEVEL INCREASED | 9 0.09 33.87 DRUG RESISTANCE | 1 0.01 33.88 DRUG SCREEN POSITIVE | 3 0.03 33.91 DRUG TOXICITY | 22 0.22 34.13 DRUG WITHDRAWAL HEADACHE | 1 0.01 34.14 DRUG WITHDRAWAL SYNDROME | 14 0.14 34.28 DRY MOUTH | 21 0.21 34.49 DRY SKIN | 7 0.07 34.56 DRY THROAT | 1 0.01 34.57 DUODENAL ULCER | 2 0.02 34.59 DUODENAL ULCER HAEMORRHAGE | 3 0.03 34.62 DUODENAL ULCER PERFORATION | 1 0.01 34.63 DUODENITIS | 2 0.02 34.65 DYSARTHRIA | 6 0.06 34.71 DYSGEUSIA | 8 0.08 34.79 DYSKINESIA | 10 0.10 34.89 DYSLALIA | 3 0.03 34.92 DYSLIPIDAEMIA | 1 0.01 34.93 DYSPEPSIA | 24 0.24 35.17 DYSPHAGIA | 21 0.21 35.38 DYSPHASIA | 2 0.02 35.40 DYSPHORIA | 2 0.02 35.42 DYSPNOEA | 81 0.81 36.23 DYSPNOEA EXERTIONAL | 12 0.12 36.35 DYSSTASIA | 2 0.02 36.37 DYSTONIA | 5 0.05 36.42 DYSTROPHIC CALCIFICATION | 1 0.01 36.43 DYSURIA | 10 0.10 36.53 EAR CONGESTION | 1 0.01 36.54 EAR DISORDER | 1 0.01 36.55 EAR HAEMORRHAGE | 1 0.01 36.56 EAR INFECTION | 1 0.01 36.57 EAR PAIN | 8 0.08 36.65 EATING DISORDER | 5 0.05 36.70 ECCHYMOSIS | 1 0.01 36.71 ECHOCARDIOGRAM ABNORMAL | 1 0.01 36.72 ECONOMIC PROBLEM | 1 0.01 36.73 ECTOPIC PREGNANCY | 2 0.02 36.75 ECZEMA | 7 0.07 36.82 ECZEMA NUMMULAR | 2 0.02 36.84 EJACULATION FAILURE | 1 0.01 36.85 EJECTION FRACTION DECREASED | 9 0.09 36.94 ELECTROCARDIOGRAM ABNORMAL | 4 0.04 36.98 ELECTROCARDIOGRAM POOR R-WAVE PROGRES.. | 1 0.01 36.99 ELECTROCARDIOGRAM Q WAVE ABNORMAL | 1 0.01 37.00 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL | 1 0.01 37.01 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED | 1 0.01 37.02 ELECTROCARDIOGRAM QT CORRECTED INTERV.. | 2 0.02 37.04 ELECTROCARDIOGRAM QT PROLONGED | 2 0.02 37.06 ELECTROCARDIOGRAM REPOLARISATION ABNO.. | 1 0.01 37.07 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL | 1 0.01 37.08 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION | 2 0.02 37.10 ELECTROCARDIOGRAM T WAVE ABNORMAL | 4 0.04 37.14 ELECTROCARDIOGRAM T WAVE INVERSION | 2 0.02 37.16 ELECTROCUTION | 1 0.01 37.17 ELECTROENCEPHALOGRAM ABNORMAL | 3 0.03 37.20 ELECTROMECHANICAL DISSOCIATION | 2 0.02 37.22 EMBOLIC STROKE | 1 0.01 37.23 EMOTIONAL DISORDER | 8 0.08 37.31 EMOTIONAL DISTRESS | 18 0.18 37.49 EMPHYSEMA | 1 0.01 37.50 EMPTY SELLA SYNDROME | 1 0.01 37.51 ENCEPHALITIS | 2 0.02 37.53 ENCEPHALITIS HERPES | 1 0.01 37.54 ENCEPHALITIS VIRAL | 1 0.01 37.55 ENCEPHALOPATHY | 9 0.09 37.64 ENDOCARDITIS BACTERIAL | 1 0.01 37.65 ENDOMETRIAL CANCER STAGE I | 1 0.01 37.66 ENDOTOXIC SHOCK | 1 0.01 37.67 ENERGY INCREASED | 1 0.01 37.68 ENTERITIS | 2 0.02 37.70 ENTEROBACTER BACTERAEMIA | 1 0.01 37.71 ENTEROBACTER INFECTION | 2 0.02 37.73 ENTEROCOCCAL INFECTION | 1 0.01 37.74 ENTEROCOLITIS HAEMORRHAGIC | 1 0.01 37.75 ENTEROCUTANEOUS FISTULA | 1 0.01 37.76 ENTEROVESICAL FISTULA | 1 0.01 37.77 ENURESIS | 3 0.03 37.80 EOSINOPHIL COUNT DECREASED | 1 0.01 37.81 EOSINOPHIL COUNT INCREASED | 3 0.03 37.84 EOSINOPHILIA | 5 0.05 37.89 EOSINOPHILIC PNEUMONIA | 2 0.02 37.91 EOSINOPHILIC PNEUMONIA ACUTE | 1 0.01 37.92 EOSINOPHILIC PNEUMONIA CHRONIC | 1 0.01 37.93 EPENDYMOMA | 1 0.01 37.94 EPIGASTRIC DISCOMFORT | 1 0.01 37.95 EPIGLOTTITIS | 1 0.01 37.96 EPILEPSY | 5 0.05 38.01 EPISTAXIS | 16 0.16 38.17 EPSTEIN-BARR VIRUS ANTIBODY POSITIVE | 2 0.02 38.19 EPSTEIN-BARR VIRUS INFECTION | 2 0.02 38.21 ERECTILE DYSFUNCTION | 7 0.07 38.28 ERUCTATION | 3 0.03 38.31 ERYSIPELAS | 1 0.01 38.32 ERYTHEMA | 29 0.29 38.61 ERYTHEMA MULTIFORME | 3 0.03 38.64 ESCHERICHIA BACTERAEMIA | 2 0.02 38.66 ESCHERICHIA INFECTION | 1 0.01 38.67 EUPHORIC MOOD | 1 0.01 38.68 EXANTHEM | 5 0.05 38.73 EXCORIATION | 11 0.11 38.84 EXERCISE LACK OF | 1 0.01 38.85 EXOSTOSIS | 3 0.03 38.88 EXPOSURE TO COMMUNICABLE DISEASE | 2 0.02 38.90 EXTRADURAL ABSCESS | 2 0.02 38.92 EXTRASYSTOLES | 1 0.01 38.93 EXTRAVASATION | 2 0.02 38.95 EYE DISORDER | 11 0.11 39.06 EYE HAEMORRHAGE | 8 0.08 39.14 EYE INFLAMMATION | 1 0.01 39.15 EYE INJURY | 2 0.02 39.17 EYE IRRITATION | 4 0.04 39.21 EYE MOVEMENT DISORDER | 1 0.01 39.22 EYE OEDEMA | 2 0.02 39.24 EYE PAIN | 5 0.05 39.29 EYE PRURITUS | 5 0.05 39.34 EYE REDNESS | 9 0.09 39.43 EYE SWELLING | 6 0.06 39.49 EYELID OEDEMA | 3 0.03 39.52 EYELID PTOSIS | 4 0.04 39.56 FACE OEDEMA | 10 0.10 39.66 FACIAL BONES FRACTURE | 1 0.01 39.67 FACIAL NERVE DISORDER | 1 0.01 39.68 FACIAL PAIN | 2 0.02 39.70 FACIAL PALSY | 2 0.02 39.72 FAECAL INCONTINENCE | 4 0.04 39.76 FAECAL OCCULT BLOOD POSITIVE | 1 0.01 39.77 FAECES DISCOLOURED | 8 0.08 39.85 FAECES HARD | 2 0.02 39.87 FAECES PALE | 2 0.02 39.89 FAILURE TO THRIVE | 4 0.04 39.93 FALL | 57 0.57 40.50 FAMILY STRESS | 1 0.01 40.51 FAT ATROPHY | 1 0.01 40.52 FAT TISSUE INCREASED | 1 0.01 40.53 FATIGUE | 97 0.97 41.50 FEAR | 1 0.01 41.51 FEBRILE NEUTROPENIA | 7 0.07 41.58 FEEDING PROBLEM IN NEWBORN | 1 0.01 41.59 FEEDING TUBE COMPLICATION | 2 0.02 41.61 FEELING ABNORMAL | 45 0.45 42.06 FEELING COLD | 2 0.02 42.08 FEELING DRUNK | 1 0.01 42.09 FEELING HOT | 10 0.10 42.19 FEELING HOT AND COLD | 2 0.02 42.21 FEELING JITTERY | 3 0.03 42.24 FEMUR FRACTURE | 3 0.03 42.27 FIBRIN D DIMER INCREASED | 1 0.01 42.28 FIBROMYALGIA | 2 0.02 42.30 FIBROSIS | 1 0.01 42.31 FISTULA | 2 0.02 42.33 FLANK PAIN | 3 0.03 42.36 FLAT AFFECT | 1 0.01 42.37 FLATULENCE | 21 0.21 42.58 FLUID INTAKE REDUCED | 1 0.01 42.59 FLUID OVERLOAD | 3 0.03 42.62 FLUID RETENTION | 10 0.10 42.72 FLUSHING | 14 0.14 42.86 FOETAL DISORDER | 1 0.01 42.87 FOETAL GROWTH RETARDATION | 1 0.01 42.88 FOETAL HEART RATE ABNORMAL | 2 0.02 42.90 FOETAL MALFORMATION | 3 0.03 42.93 FOLATE DEFICIENCY | 1 0.01 42.94 FOLLICULITIS | 2 0.02 42.96 FOOD ALLERGY | 2 0.02 42.98 FOOD AVERSION | 1 0.01 42.99 FOOD CRAVING | 1 0.01 43.00 FOOD INTERACTION | 1 0.01 43.01 FOOD POISONING | 1 0.01 43.02 FOOT FRACTURE | 3 0.03 43.05 FOREIGN BODY TRAUMA | 1 0.01 43.06 FORMICATION | 2 0.02 43.08 FRACTURE | 4 0.04 43.12 FREQUENT BOWEL MOVEMENTS | 1 0.01 43.13 FROSTBITE | 1 0.01 43.14 FULL BLOOD COUNT DECREASED | 1 0.01 43.15 FULL BLOOD COUNT INCREASED | 1 0.01 43.16 FUNGAL INFECTION | 1 0.01 43.17 FURUNCLE | 1 0.01 43.18 GAIT DISTURBANCE | 14 0.14 43.32 GAIT SPASTIC | 1 0.01 43.33 GALACTORRHOEA | 1 0.01 43.34 GALLBLADDER CHOLESTEROLOSIS | 1 0.01 43.35 GALLBLADDER DISORDER | 3 0.03 43.38 GALLBLADDER PAIN | 1 0.01 43.39 GALLOP RHYTHM PRESENT | 1 0.01 43.40 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 24 0.24 43.64 GANGRENE | 1 0.01 43.65 GAS POISONING | 1 0.01 43.66 GASTRIC CANCER | 1 0.01 43.67 GASTRIC DISORDER | 6 0.06 43.73 GASTRIC HAEMORRHAGE | 2 0.02 43.75 GASTRIC INFECTION | 1 0.01 43.76 GASTRIC MUCOSAL LESION | 1 0.01 43.77 GASTRIC PERFORATION | 1 0.01 43.78 GASTRIC ULCER | 1 0.01 43.79 GASTRIC ULCER HAEMORRHAGE | 3 0.03 43.82 GASTRIC ULCER PERFORATION | 1 0.01 43.83 GASTRITIS | 11 0.11 43.94 GASTRITIS EROSIVE | 2 0.02 43.96 GASTROENTERITIS | 2 0.02 43.98 GASTROENTERITIS RADIATION | 1 0.01 43.99 GASTROENTERITIS STAPHYLOCOCCAL | 1 0.01 44.00 GASTROENTERITIS VIRAL | 3 0.03 44.03 GASTROINTESTINAL DISORDER | 13 0.13 44.16 GASTROINTESTINAL HAEMORRHAGE | 16 0.16 44.32 GASTROINTESTINAL MOTILITY DISORDER | 1 0.01 44.33 GASTROINTESTINAL MUCOSAL DISORDER | 4 0.04 44.37 GASTROINTESTINAL NECROSIS | 1 0.01 44.38 GASTROINTESTINAL OBSTRUCTION | 1 0.01 44.39 GASTROINTESTINAL PAIN | 4 0.04 44.43 GASTROINTESTINAL PERFORATION | 2 0.02 44.45 GASTROINTESTINAL ULCER | 2 0.02 44.47 GASTROOESOPHAGEAL REFLUX DISEASE | 16 0.16 44.63 GAZE PALSY | 1 0.01 44.64 GENERAL PHYSICAL HEALTH DETERIORATION | 17 0.17 44.81 GENERALISED ANXIETY DISORDER | 1 0.01 44.82 GENERALISED OEDEMA | 7 0.07 44.89 GENITAL PAIN | 1 0.01 44.90 GENITAL PRURITUS FEMALE | 1 0.01 44.91 GENITAL PRURITUS MALE | 1 0.01 44.92 GENITAL RASH | 2 0.02 44.94 GINGIVAL BLEEDING | 5 0.05 44.99 GINGIVAL BLISTER | 1 0.01 45.00 GINGIVAL HYPERPLASIA | 6 0.06 45.06 GINGIVAL SWELLING | 1 0.01 45.07 GLAUCOMA | 6 0.06 45.13 GLIOSIS | 1 0.01 45.14 GLOMERULONEPHRITIS FOCAL | 4 0.04 45.18 GLOSSITIS | 4 0.04 45.22 GLOSSODYNIA | 2 0.02 45.24 GLOSSOPTOSIS | 1 0.01 45.25 GLUCOSE TOLERANCE IMPAIRED | 1 0.01 45.26 GLUCOSE TOLERANCE TEST ABNORMAL | 1 0.01 45.27 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEF.. | 1 0.01 45.28 GLUTAMATE DEHYDROGENASE INCREASED | 1 0.01 45.29 GLYCOSYLATED HAEMOGLOBIN INCREASED | 4 0.04 45.33 GOUT | 5 0.05 45.38 GOUTY ARTHRITIS | 1 0.01 45.39 GRAFT COMPLICATION | 1 0.01 45.40 GRAFT DYSFUNCTION | 1 0.01 45.41 GRAFT LOSS | 4 0.04 45.45 GRAFT VERSUS HOST DISEASE | 3 0.03 45.48 GRAND MAL CONVULSION | 16 0.16 45.64 GRANULOCYTE COUNT DECREASED | 1 0.01 45.65 GRANULOCYTES MATURATION ARREST | 1 0.01 45.66 GRAVITATIONAL OEDEMA | 1 0.01 45.67 GROIN PAIN | 4 0.04 45.71 GROWTH RETARDATION | 1 0.01 45.72 GUN SHOT WOUND | 2 0.02 45.74 GYNAECOMASTIA | 5 0.05 45.79 HAEMANGIOMA | 1 0.01 45.80 HAEMATEMESIS | 11 0.11 45.91 HAEMATOCHEZIA | 11 0.11 46.02 HAEMATOCRIT DECREASED | 9 0.09 46.11 HAEMATOCRIT INCREASED | 1 0.01 46.12 HAEMATOMA | 10 0.10 46.22 HAEMATOMA INFECTION | 1 0.01 46.23 HAEMATOSPERMIA | 1 0.01 46.24 HAEMATURIA | 5 0.05 46.29 HAEMOCHROMATOSIS | 1 0.01 46.30 HAEMODIALYSIS | 10 0.10 46.40 HAEMODYNAMIC INSTABILITY | 3 0.03 46.43 HAEMOGLOBIN DECREASED | 29 0.29 46.72 HAEMOGLOBIN INCREASED | 2 0.02 46.74 HAEMOLYSIS | 2 0.02 46.76 HAEMOLYTIC ANAEMIA | 4 0.04 46.80 HAEMOPHILUS INFECTION | 1 0.01 46.81 HAEMOPTYSIS | 4 0.04 46.85 HAEMORRHAGE | 15 0.15 47.00 HAEMORRHAGE INTRACRANIAL | 2 0.02 47.02 HAEMORRHAGE SUBCUTANEOUS | 1 0.01 47.03 HAEMORRHAGE URINARY TRACT | 1 0.01 47.04 HAEMORRHAGIC CEREBRAL INFARCTION | 1 0.01 47.05 HAEMORRHAGIC DIATHESIS | 1 0.01 47.06 HAEMORRHAGIC STROKE | 1 0.01 47.07 HAEMORRHAGIC TUMOUR NECROSIS | 1 0.01 47.08 HAEMORRHOIDAL HAEMORRHAGE | 1 0.01 47.09 HAEMORRHOIDS | 9 0.09 47.18 HAIR COLOUR CHANGES | 1 0.01 47.19 HALITOSIS | 1 0.01 47.20 HALLUCINATION | 14 0.14 47.34 HALLUCINATION, AUDITORY | 5 0.05 47.39 HALLUCINATION, VISUAL | 4 0.04 47.43 HALLUCINATIONS, MIXED | 1 0.01 47.44 HALO VISION | 1 0.01 47.45 HAND DERMATITIS | 1 0.01 47.46 HEAD DISCOMFORT | 2 0.02 47.48 HEAD INJURY | 2 0.02 47.50 HEADACHE | 82 0.82 48.32 HEARING IMPAIRED | 5 0.05 48.37 HEART DISEASE CONGENITAL | 1 0.01 48.38 HEART INJURY | 2 0.02 48.40 HEART RATE DECREASED | 2 0.02 48.42 HEART RATE INCREASED | 23 0.23 48.65 HEART RATE IRREGULAR | 11 0.11 48.76 HEART TRANSPLANT | 1 0.01 48.77 HEART VALVE REPLACEMENT | 1 0.01 48.78 HELICOBACTER GASTRITIS | 2 0.02 48.80 HELICOBACTER INFECTION | 1 0.01 48.81 HELICOBACTER PYLORI IDENTIFICATION TE.. | 1 0.01 48.82 HEMIPARESIS | 6 0.06 48.88 HEMIPLEGIA | 2 0.02 48.90 HEPARIN-INDUCED THROMBOCYTOPENIA | 2 0.02 48.92 HEPARIN-INDUCED THROMBOCYTOPENIA TEST | 1 0.01 48.93 HEPATIC ARTERY THROMBOSIS | 1 0.01 48.94 HEPATIC CIRRHOSIS | 4 0.04 48.98 HEPATIC CONGESTION | 3 0.03 49.01 HEPATIC CYST | 1 0.01 49.02 HEPATIC ENCEPHALOPATHY | 2 0.02 49.04 HEPATIC ENZYME INCREASED | 22 0.22 49.26 HEPATIC FAILURE | 11 0.11 49.37 HEPATIC FUNCTION ABNORMAL | 14 0.14 49.51 HEPATIC HAEMATOMA | 3 0.03 49.54 HEPATIC INFECTION | 1 0.01 49.55 HEPATIC MASS | 2 0.02 49.57 HEPATIC NECROSIS | 4 0.04 49.61 HEPATIC NEOPLASM | 2 0.02 49.63 HEPATIC NEOPLASM MALIGNANT | 1 0.01 49.64 HEPATIC NEOPLASM MALIGNANT NON-RESECT.. | 1 0.01 49.65 HEPATIC PAIN | 3 0.03 49.68 HEPATIC STEATOSIS | 8 0.08 49.76 HEPATITIS | 13 0.13 49.89 HEPATITIS ACUTE | 1 0.01 49.90 HEPATITIS B | 2 0.02 49.92 HEPATITIS B SURFACE ANTIGEN POSITIVE | 1 0.01 49.93 HEPATITIS B VIRUS | 1 0.01 49.94 HEPATITIS C | 2 0.02 49.96 HEPATITIS C ANTIBODY POSITIVE | 1 0.01 49.97 HEPATITIS CHOLESTATIC | 4 0.04 50.01 HEPATITIS FULMINANT | 7 0.07 50.08 HEPATITIS GRANULOMATOUS | 2 0.02 50.10 HEPATITIS VIRAL | 1 0.01 50.11 HEPATOCELLULAR DAMAGE | 5 0.05 50.16 HEPATOJUGULAR REFLUX | 1 0.01 50.17 HEPATOMEGALY | 3 0.03 50.20 HEPATOSPLENOMEGALY | 2 0.02 50.22 HEPATOTOXICITY | 2 0.02 50.24 HERNIA | 1 0.01 50.25 HERNIA REPAIR | 1 0.01 50.26 HERPANGINA | 1 0.01 50.27 HERPES SIMPLEX | 1 0.01 50.28 HERPES SIMPLEX SEROLOGY POSITIVE | 1 0.01 50.29 HERPES VIRUS INFECTION | 2 0.02 50.31 HERPES ZOSTER | 4 0.04 50.35 HIATUS HERNIA | 7 0.07 50.42 HICCUPS | 2 0.02 50.44 HIGH DENSITY LIPOPROTEIN DECREASED | 27 0.27 50.71 HIGH DENSITY LIPOPROTEIN INCREASED | 3 0.03 50.74 HIGH-PITCHED CRYING | 1 0.01 50.75 HIP ARTHROPLASTY | 2 0.02 50.77 HIP FRACTURE | 9 0.09 50.86 HIRSUTISM | 7 0.07 50.93 HISTIOCYTOSIS HAEMATOPHAGIC | 1 0.01 50.94 HIV WASTING SYNDROME | 1 0.01 50.95 HOARSENESS | 8 0.08 51.03 HODGKIN'S DISEASE | 1 0.01 51.04 HOMANS' SIGN | 1 0.01 51.05 HOMICIDAL IDEATION | 2 0.02 51.07 HOSPITALISATION | 1 0.01 51.08 HOSTILITY | 2 0.02 51.10 HOT FLUSH | 10 0.10 51.20 HUMAN HERPESVIRUS 6 INFECTION | 1 0.01 51.21 HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE .. | 1 0.01 51.22 HYDROCEPHALUS | 5 0.05 51.27 HYDRONEPHROSIS | 4 0.04 51.31 HYDROPS FOETALIS | 1 0.01 51.32 HYPERAESTHESIA | 2 0.02 51.34 HYPERAMMONAEMIA | 1 0.01 51.35 HYPERCALCAEMIA | 3 0.03 51.38 HYPERCAPNIA | 1 0.01 51.39 HYPERCHOLESTEROLAEMIA | 6 0.06 51.45 HYPERCOAGULATION | 1 0.01 51.46 HYPERGLYCAEMIA | 3 0.03 51.49 HYPERHIDROSIS | 24 0.24 51.73 HYPERKALAEMIA | 7 0.07 51.80 HYPERLIPIDAEMIA | 7 0.07 51.87 HYPERNATRAEMIA | 2 0.02 51.89 HYPERPHAGIA | 1 0.01 51.90 HYPERPHOSPHATAEMIA | 1 0.01 51.91 HYPERPYREXIA | 1 0.01 51.92 HYPERSENSITIVITY | 24 0.24 52.16 HYPERSOMNIA | 2 0.02 52.18 HYPERTENSION | 51 0.51 52.69 HYPERTENSIVE CRISIS | 3 0.03 52.72 HYPERTHERMIA | 1 0.01 52.73 HYPERTHYROIDISM | 4 0.04 52.77 HYPERTONIA | 1 0.01 52.78 HYPERTONIC BLADDER | 1 0.01 52.79 HYPERTRIGLYCERIDAEMIA | 1 0.01 52.80 HYPERTROPHY BREAST | 3 0.03 52.83 HYPERURICAEMIA | 1 0.01 52.84 HYPERVENTILATION | 4 0.04 52.88 HYPOACUSIS | 2 0.02 52.90 HYPOAESTHESIA | 28 0.28 53.18 HYPOAESTHESIA ORAL | 3 0.03 53.21 HYPOALBUMINAEMIA | 1 0.01 53.22 HYPOCALCAEMIA | 7 0.07 53.29 HYPOCHROMIC ANAEMIA | 2 0.02 53.31 HYPOGAMMAGLOBULINAEMIA | 2 0.02 53.33 HYPOGEUSIA | 1 0.01 53.34 HYPOGLYCAEMIA | 13 0.13 53.47 HYPOGLYCAEMIA NEONATAL | 3 0.03 53.50 HYPOGLYCAEMIC COMA | 1 0.01 53.51 HYPOKALAEMIA | 12 0.12 53.63 HYPOKINESIA | 2 0.02 53.65 HYPOMAGNESAEMIA | 4 0.04 53.69 HYPOMANIA | 1 0.01 53.70 HYPONATRAEMIA | 9 0.09 53.79 HYPOPHOSPHATAEMIA | 1 0.01 53.80 HYPOPLASTIC LEFT HEART SYNDROME | 1 0.01 53.81 HYPOTENSION | 40 0.40 54.21 HYPOTHERMIA | 1 0.01 54.22 HYPOTHYROIDISM | 2 0.02 54.24 HYPOTONIA | 2 0.02 54.26 HYPOTRICHOSIS | 3 0.03 54.29 HYPOVENTILATION | 4 0.04 54.33 HYPOVITAMINOSIS | 1 0.01 54.34 HYPOVOLAEMIC SHOCK | 2 0.02 54.36 HYPOXIA | 2 0.02 54.38 HYPOXIC ENCEPHALOPATHY | 2 0.02 54.40 HYSTERECTOMY | 2 0.02 54.42 IATROGENIC INJURY | 3 0.03 54.45 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 1 0.01 54.46 IDIOSYNCRATIC DRUG REACTION | 1 0.01 54.47 ILEITIS | 1 0.01 54.48 ILEUS | 6 0.06 54.54 ILEUS PARALYTIC | 6 0.06 54.60 ILIUM FRACTURE | 1 0.01 54.61 ILL-DEFINED DISORDER | 6 0.06 54.67 IMMOBILE | 2 0.02 54.69 IMMUNE RECONSTITUTION SYNDROME | 2 0.02 54.71 IMMUNE SYSTEM DISORDER | 1 0.01 54.72 IMMUNOSUPPRESSION | 1 0.01 54.73 IMPAIRED GASTRIC EMPTYING | 1 0.01 54.74 IMPAIRED HEALING | 6 0.06 54.80 IMPAIRED SELF-CARE | 2 0.02 54.82 IMPAIRED WORK ABILITY | 3 0.03 54.85 IMPLANT EXPULSION | 1 0.01 54.86 IMPLANT SITE HAEMORRHAGE | 1 0.01 54.87 IMPLANT SITE INFECTION | 1 0.01 54.88 IMPLANT SITE REACTION | 2 0.02 54.90 IMPLANTABLE DEFIBRILLATOR MALFUNCTION | 1 0.01 54.91 IMPRISONMENT | 1 0.01 54.92 IMPULSIVE BEHAVIOUR | 3 0.03 54.95 INADEQUATE ANALGESIA | 1 0.01 54.96 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 2 0.02 54.98 INCISION SITE COMPLICATION | 1 0.01 54.99 INCOHERENT | 1 0.01 55.00 INCONTINENCE | 3 0.03 55.03 INCREASED APPETITE | 1 0.01 55.04 INCREASED UPPER AIRWAY SECRETION | 1 0.01 55.05 INDURATION | 2 0.02 55.07 INFANTILE SPASMS | 1 0.01 55.08 INFECTED SKIN ULCER | 1 0.01 55.09 INFECTION | 14 0.14 55.23 INFECTION IN AN IMMUNOCOMPROMISED HOST | 2 0.02 55.25 INFLAMMATION | 5 0.05 55.30 INFLAMMATION LOCALISED | 1 0.01 55.31 INFLUENZA | 10 0.10 55.41 INFLUENZA LIKE ILLNESS | 11 0.11 55.52 INFUSION RELATED REACTION | 4 0.04 55.56 INFUSION SITE ERYTHEMA | 2 0.02 55.58 INFUSION SITE INDURATION | 1 0.01 55.59 INFUSION SITE PAIN | 1 0.01 55.60 INFUSION SITE PRURITUS | 2 0.02 55.62 INFUSION SITE RASH | 1 0.01 55.63 INFUSION SITE REACTION | 4 0.04 55.67 INGUINAL HERNIA, OBSTRUCTIVE | 1 0.01 55.68 INJECTION SITE BURNING | 1 0.01 55.69 INJECTION SITE DISCOLOURATION | 1 0.01 55.70 INJECTION SITE DISCOMFORT | 1 0.01 55.71 INJECTION SITE ERYTHEMA | 4 0.04 55.75 INJECTION SITE EXTRAVASATION | 1 0.01 55.76 INJECTION SITE HAEMORRHAGE | 6 0.06 55.82 INJECTION SITE INDURATION | 2 0.02 55.84 INJECTION SITE INFECTION | 1 0.01 55.85 INJECTION SITE IRRITATION | 1 0.01 55.86 INJECTION SITE MASS | 2 0.02 55.88 INJECTION SITE NECROSIS | 1 0.01 55.89 INJECTION SITE NODULE | 1 0.01 55.90 INJECTION SITE OEDEMA | 1 0.01 55.91 INJECTION SITE PAIN | 8 0.08 55.99 INJECTION SITE PRURITUS | 3 0.03 56.02 INJECTION SITE RASH | 1 0.01 56.03 INJECTION SITE REACTION | 3 0.03 56.06 INJECTION SITE STINGING | 3 0.03 56.09 INJECTION SITE SWELLING | 2 0.02 56.11 INJECTION SITE ULCER | 1 0.01 56.12 INJECTION SITE VESICLES | 2 0.02 56.14 INJECTION SITE WARMTH | 1 0.01 56.15 INJURY | 14 0.14 56.29 INNER EAR DISORDER | 3 0.03 56.32 INSOMNIA | 51 0.51 56.83 INTENTIONAL MISUSE | 2 0.02 56.85 INTENTIONAL OVERDOSE | 4 0.04 56.89 INTERNATIONAL NORMALISED RATIO ABNORMAL | 3 0.03 56.92 INTERNATIONAL NORMALISED RATIO DECREA.. | 2 0.02 56.94 INTERNATIONAL NORMALISED RATIO INCREA.. | 14 0.14 57.08 INTERSTITIAL LUNG DISEASE | 8 0.08 57.16 INTERVERTEBRAL DISC DEGENERATION | 9 0.09 57.25 INTERVERTEBRAL DISC DISORDER | 3 0.03 57.28 INTERVERTEBRAL DISC DISPLACEMENT | 1 0.01 57.29 INTERVERTEBRAL DISC PROTRUSION | 6 0.06 57.35 INTERVERTEBRAL DISCITIS | 2 0.02 57.37 INTESTINAL FISTULA | 1 0.01 57.38 INTESTINAL HAEMORRHAGE | 2 0.02 57.40 INTESTINAL OBSTRUCTION | 4 0.04 57.44 INTESTINAL PERFORATION | 2 0.02 57.46 INTESTINAL SPASM | 1 0.01 57.47 INTESTINAL STOMA COMPLICATION | 1 0.01 57.48 INTRA-ABDOMINAL HAEMORRHAGE | 1 0.01 57.49 INTRA-UTERINE DEATH | 2 0.02 57.51 INTRACARDIAC THROMBUS | 2 0.02 57.53 INTRACRANIAL PRESSURE INCREASED | 2 0.02 57.55 INTRAOCULAR PRESSURE INCREASED | 1 0.01 57.56 INTUBATION | 1 0.01 57.57 IRITIS | 1 0.01 57.58 IRON DEFICIENCY ANAEMIA | 4 0.04 57.62 IRRITABILITY | 10 0.10 57.72 IRRITABLE BOWEL SYNDROME | 3 0.03 57.75 ISCHAEMIA | 2 0.02 57.77 ISCHAEMIC CARDIOMYOPATHY | 3 0.03 57.80 ISCHAEMIC CEREBRAL INFARCTION | 1 0.01 57.81 ISCHAEMIC STROKE | 1 0.01 57.82 JAUNDICE | 20 0.20 58.02 JAUNDICE CHOLESTATIC | 1 0.01 58.03 JAUNDICE NEONATAL | 1 0.01 58.04 JAW DISORDER | 3 0.03 58.07 JAW FRACTURE | 1 0.01 58.08 JOINT ANKYLOSIS | 1 0.01 58.09 JOINT CREPITATION | 1 0.01 58.10 JOINT DISLOCATION | 3 0.03 58.13 JOINT EFFUSION | 3 0.03 58.16 JOINT HYPEREXTENSION | 1 0.01 58.17 JOINT INJURY | 7 0.07 58.24 JOINT RANGE OF MOTION DECREASED | 1 0.01 58.25 JOINT SPRAIN | 5 0.05 58.30 JOINT STIFFNESS | 3 0.03 58.33 JOINT SWELLING | 10 0.10 58.43 JOINT WARMTH | 1 0.01 58.44 JUGULAR VEIN DISTENSION | 2 0.02 58.46 KERATOCONJUNCTIVITIS SICCA | 6 0.06 58.52 KIDNEY INFECTION | 1 0.01 58.53 KIDNEY TRANSPLANT REJECTION | 2 0.02 58.55 KLEBSIELLA INFECTION | 1 0.01 58.56 KNEE ARTHROPLASTY | 1 0.01 58.57 KYPHOSIS | 1 0.01 58.58 LABILE BLOOD PRESSURE | 1 0.01 58.59 LABORATORY TEST ABNORMAL | 1 0.01 58.60 LABYRINTHITIS | 1 0.01 58.61 LACERATION | 2 0.02 58.63 LACK OF SPONTANEOUS SPEECH | 1 0.01 58.64 LACRIMAL DISORDER | 1 0.01 58.65 LACRIMATION INCREASED | 4 0.04 58.69 LACTIC ACIDOSIS | 5 0.05 58.74 LACUNAR INFARCTION | 1 0.01 58.75 LANGERHANS' CELL GRANULOMATOSIS | 1 0.01 58.76 LARGE INTESTINAL ULCER HAEMORRHAGE | 1 0.01 58.77 LARGE INTESTINE PERFORATION | 3 0.03 58.80 LARYNGEAL OEDEMA | 1 0.01 58.81 LARYNGOTRACHEO BRONCHITIS | 1 0.01 58.82 LASER THERAPY | 1 0.01 58.83 LATE DEVELOPER | 1 0.01 58.84 LEFT VENTRICULAR END-DIASTOLIC PRESSU.. | 2 0.02 58.86 LEFT VENTRICULAR FAILURE | 1 0.01 58.87 LEG AMPUTATION | 2 0.02 58.89 LENS DISORDER | 1 0.01 58.90 LENTICULAR OPACITIES | 2 0.02 58.92 LETHARGY | 13 0.13 59.05 LEUKAEMIA | 1 0.01 59.06 LEUKAEMIA PLASMACYTIC | 1 0.01 59.07 LEUKAEMIA RECURRENT | 1 0.01 59.08 LEUKOCYTOCLASTIC VASCULITIS | 1 0.01 59.09 LEUKOCYTOSIS | 6 0.06 59.15 LEUKOENCEPHALOMYELITIS | 1 0.01 59.16 LEUKOENCEPHALOPATHY | 1 0.01 59.17 LEUKOPENIA | 12 0.12 59.29 LIBIDO DECREASED | 4 0.04 59.33 LICHEN PLANUS | 1 0.01 59.34 LIGAMENT INJURY | 1 0.01 59.35 LIMB DISCOMFORT | 2 0.02 59.37 LIMB OPERATION | 1 0.01 59.38 LIP BLISTER | 1 0.01 59.39 LIP PAIN | 1 0.01 59.40 LIP SLOUGHING | 1 0.01 59.41 LIPASE INCREASED | 4 0.04 59.45 LIPID METABOLISM DISORDER | 1 0.01 59.46 LIPIDS INCREASED | 1 0.01 59.47 LIPOPROTEIN (A) INCREASED | 1 0.01 59.48 LISTLESS | 3 0.03 59.51 LIVE BIRTH | 1 0.01 59.52 LIVER DISORDER | 16 0.16 59.68 LIVER FUNCTION TEST ABNORMAL | 18 0.18 59.86 LIVER TRANSPLANT | 2 0.02 59.88 LIVER TRANSPLANT REJECTION | 3 0.03 59.91 LOBAR PNEUMONIA | 3 0.03 59.94 LOCAL SWELLING | 2 0.02 59.96 LOCALISED EXFOLIATION | 1 0.01 59.97 LOCALISED INFECTION | 3 0.03 60.00 LOCALISED OEDEMA | 1 0.01 60.01 LOCALISED OSTEOARTHRITIS | 5 0.05 60.06 LOCKED-IN SYNDROME | 1 0.01 60.07 LOEFFLER'S SYNDROME | 1 0.01 60.08 LOGORRHOEA | 2 0.02 60.10 LOOSE STOOLS | 4 0.04 60.14 LOSS OF CONSCIOUSNESS | 41 0.41 60.55 LOSS OF CONTROL OF LEGS | 2 0.02 60.57 LOSS OF EMPLOYMENT | 1 0.01 60.58 LOSS OF LIBIDO | 4 0.04 60.62 LOW DENSITY LIPOPROTEIN DECREASED | 1 0.01 60.63 LOW DENSITY LIPOPROTEIN INCREASED | 14 0.14 60.77 LOWER GASTROINTESTINAL HAEMORRHAGE | 5 0.05 60.82 LOWER LIMB FRACTURE | 2 0.02 60.84 LOWER RESPIRATORY TRACT INFECTION | 1 0.01 60.85 LUMBAR PUNCTURE ABNORMAL | 1 0.01 60.86 LUMBAR PUNCTURE HEADACHE | 1 0.01 60.87 LUMBAR RADICULOPATHY | 2 0.02 60.89 LUMBAR SPINAL STENOSIS | 1 0.01 60.90 LUMBAR VERTEBRAL FRACTURE | 1 0.01 60.91 LUNG ABSCESS | 1 0.01 60.92 LUNG CANCER METASTATIC | 1 0.01 60.93 LUNG CONSOLIDATION | 2 0.02 60.95 LUNG CREPITATION | 1 0.01 60.96 LUNG DISORDER | 11 0.11 61.07 LUNG INFECTION | 2 0.02 61.09 LUNG INFILTRATION | 3 0.03 61.12 LUNG INJURY | 1 0.01 61.13 LUNG NEOPLASM | 5 0.05 61.18 LUNG NEOPLASM MALIGNANT | 5 0.05 61.23 LUPUS-LIKE SYNDROME | 1 0.01 61.24 LYMPH NODE TUBERCULOSIS | 1 0.01 61.25 LYMPHADENITIS | 1 0.01 61.26 LYMPHADENOPATHY | 10 0.10 61.36 LYMPHADENOPATHY MEDIASTINAL | 1 0.01 61.37 LYMPHOCYTE COUNT DECREASED | 4 0.04 61.41 LYMPHOCYTE PERCENTAGE DECREASED | 1 0.01 61.42 LYMPHOCYTE STIMULATION TEST POSITIVE | 2 0.02 61.44 LYMPHOCYTIC INFILTRATION | 1 0.01 61.45 LYMPHOMA | 3 0.03 61.48 LYMPHOPENIA | 1 0.01 61.49 LYMPHOPROLIFERATIVE DISORDER | 1 0.01 61.50 MACROCYTOSIS | 1 0.01 61.51 MACULAR DEGENERATION | 2 0.02 61.53 MACULAR OEDEMA | 5 0.05 61.58 MACULOPATHY | 1 0.01 61.59 MAJOR DEPRESSION | 4 0.04 61.63 MALABSORPTION | 1 0.01 61.64 MALAISE | 39 0.39 62.03 MALE SEXUAL DYSFUNCTION | 1 0.01 62.04 MALIGNANT ASCITES | 1 0.01 62.05 MALIGNANT HYPERTENSION | 1 0.01 62.06 MALIGNANT NEOPLASM PROGRESSION | 10 0.10 62.16 MALIGNANT PLEURAL EFFUSION | 1 0.01 62.17 MALLORY-WEISS SYNDROME | 2 0.02 62.19 MALNUTRITION | 1 0.01 62.20 MANIA | 5 0.05 62.25 MARKEDLY REDUCED DIETARY INTAKE | 7 0.07 62.32 MARROW HYPERPLASIA | 1 0.01 62.33 MASS | 2 0.02 62.35 MASTICATION DISORDER | 1 0.01 62.36 MASTOIDITIS | 1 0.01 62.37 MATERNAL DRUGS AFFECTING FOETUS | 1 0.01 62.38 MEDIASTINITIS | 1 0.01 62.39 MEDICAL DEVICE COMPLICATION | 7 0.07 62.46 MEDICATION ERROR | 60 0.60 63.06 MELAENA | 4 0.04 63.10 MELANODERMIA | 1 0.01 63.11 MEMORY IMPAIRMENT | 13 0.13 63.24 MENINGITIS | 2 0.02 63.26 MENINGITIS ASEPTIC | 1 0.01 63.27 MENINGITIS TUBERCULOUS | 1 0.01 63.28 MENINGITIS VIRAL | 1 0.01 63.29 MENISCUS LESION | 2 0.02 63.31 MENORRHAGIA | 2 0.02 63.33 MENSTRUAL DISORDER | 2 0.02 63.35 MENTAL DISORDER | 6 0.06 63.41 MENTAL IMPAIRMENT | 4 0.04 63.45 MENTAL STATUS CHANGES | 6 0.06 63.51 MESOTHELIOMA | 1 0.01 63.52 METABOLIC ACIDOSIS | 3 0.03 63.55 METABOLIC ALKALOSIS | 1 0.01 63.56 METASTASES TO BONE | 3 0.03 63.59 METASTASES TO CENTRAL NERVOUS SYSTEM | 2 0.02 63.61 METASTASES TO LIVER | 3 0.03 63.64 METASTASES TO LUNG | 2 0.02 63.66 METASTASES TO LYMPH NODES | 1 0.01 63.67 METASTASES TO PLEURA | 2 0.02 63.69 METASTASES TO THE MEDIASTINUM | 1 0.01 63.70 METASTATIC NEOPLASM | 3 0.03 63.73 METRORRHAGIA | 2 0.02 63.75 MICROCEPHALY | 1 0.01 63.76 MICTURITION DISORDER | 2 0.02 63.78 MICTURITION URGENCY | 3 0.03 63.81 MIDDLE INSOMNIA | 1 0.01 63.82 MIGRAINE | 13 0.13 63.95 MILK ALLERGY | 1 0.01 63.96 MIOSIS | 2 0.02 63.98 MITOCHONDRIAL CYTOPATHY | 1 0.01 63.99 MITRAL VALVE CALCIFICATION | 1 0.01 64.00 MITRAL VALVE DISEASE | 2 0.02 64.02 MITRAL VALVE INCOMPETENCE | 16 0.16 64.18 MITRAL VALVE PROLAPSE | 3 0.03 64.21 MITRAL VALVE SCLEROSIS | 1 0.01 64.22 MIXED HYPERLIPIDAEMIA | 1 0.01 64.23 MIXED INCONTINENCE | 1 0.01 64.24 MOANING | 1 0.01 64.25 MOBILITY DECREASED | 5 0.05 64.30 MONOCYTE COUNT DECREASED | 2 0.02 64.32 MONOCYTE PERCENTAGE INCREASED | 1 0.01 64.33 MONONEURITIS | 1 0.01 64.34 MOOD ALTERED | 2 0.02 64.36 MOOD SWINGS | 3 0.03 64.39 MOUTH CYST | 1 0.01 64.40 MOUTH HAEMORRHAGE | 2 0.02 64.42 MOVEMENT DISORDER | 4 0.04 64.46 MUCOSAL DISCOLOURATION | 1 0.01 64.47 MUCOSAL EROSION | 3 0.03 64.50 MUCOSAL HAEMORRHAGE | 1 0.01 64.51 MUCOSAL INFLAMMATION | 3 0.03 64.54 MUCOUS MEMBRANE DISORDER | 1 0.01 64.55 MULTI-ORGAN FAILURE | 20 0.20 64.75 MULTIPLE ALLERGIES | 2 0.02 64.77 MULTIPLE DRUG OVERDOSE | 7 0.07 64.84 MULTIPLE DRUG OVERDOSE ACCIDENTAL | 1 0.01 64.85 MULTIPLE FRACTURES | 3 0.03 64.88 MULTIPLE MYELOMA | 1 0.01 64.89 MULTIPLE SCLEROSIS | 7 0.07 64.96 MULTIPLE SCLEROSIS RELAPSE | 2 0.02 64.98 MURDER | 1 0.01 64.99 MUSCLE ATROPHY | 5 0.05 65.04 MUSCLE CONTRACTIONS INVOLUNTARY | 1 0.01 65.05 MUSCLE CONTRACTURE | 1 0.01 65.06 MUSCLE CRAMP | 28 0.28 65.34 MUSCLE DISORDER | 4 0.04 65.38 MUSCLE FATIGUE | 1 0.01 65.39 MUSCLE HAEMORRHAGE | 1 0.01 65.40 MUSCLE INJURY | 1 0.01 65.41 MUSCLE MASS | 1 0.01 65.42 MUSCLE NECROSIS | 4 0.04 65.46 MUSCLE RIGIDITY | 3 0.03 65.49 MUSCLE RUPTURE | 1 0.01 65.50 MUSCLE SPASMS | 13 0.13 65.63 MUSCLE SPASTICITY | 1 0.01 65.64 MUSCLE STRAIN | 4 0.04 65.68 MUSCLE TIGHTNESS | 7 0.07 65.75 MUSCLE TWITCHING | 6 0.06 65.81 MUSCULAR DYSTROPHY | 2 0.02 65.83 MUSCULAR WEAKNESS | 23 0.23 66.06 MUSCULOSKELETAL DISCOMFORT | 1 0.01 66.07 MUSCULOSKELETAL DISORDER | 1 0.01 66.08 MUSCULOSKELETAL PAIN | 2 0.02 66.10 MUSCULOSKELETAL STIFFNESS | 21 0.21 66.31 MYALGIA | 101 1.01 67.32 MYASTHENIA GRAVIS | 1 0.01 67.33 MYCOBACTERIUM AVIUM COMPLEX IMMUNE RE.. | 1 0.01 67.34 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 2 0.02 67.36 MYCOSIS FUNGOIDES | 1 0.01 67.37 MYDRIASIS | 3 0.03 67.40 MYELODYSPLASTIC SYNDROME | 1 0.01 67.41 MYELOID MATURATION ARREST | 1 0.01 67.42 MYELOPATHY | 1 0.01 67.43 MYOCARDIAL INFARCTION | 43 0.43 67.86 MYOCARDIAL ISCHAEMIA | 10 0.10 67.96 MYOCLONUS | 11 0.11 68.07 MYOGLOBIN BLOOD INCREASED | 3 0.03 68.10 MYOGLOBINURIA | 1 0.01 68.11 MYOPATHY | 4 0.04 68.15 MYOPATHY TOXIC | 1 0.01 68.16 MYOPIA | 1 0.01 68.17 MYOSITIS | 9 0.09 68.26 NAIL DISCOLOURATION | 1 0.01 68.27 NAIL DISORDER | 1 0.01 68.28 NASAL CONGESTION | 4 0.04 68.32 NASAL POLYPS | 1 0.01 68.33 NASOPHARYNGEAL DISORDER | 1 0.01 68.34 NASOPHARYNGITIS | 5 0.05 68.39 NAUSEA | 99 0.99 69.38 NECK PAIN | 12 0.12 69.50 NECROSIS | 1 0.01 69.51 NECROTISING FASCIITIS | 1 0.01 69.52 NEONATAL DISORDER | 3 0.03 69.55 NEONATAL RESPIRATORY FAILURE | 2 0.02 69.57 NEONATAL TACHYPNOEA | 1 0.01 69.58 NEOPLASM | 1 0.01 69.59 NEOPLASM RECURRENCE | 3 0.03 69.62 NEOVASCULARISATION | 1 0.01 69.63 NEPHRITIS INTERSTITIAL | 3 0.03 69.66 NEPHROLITHIASIS | 8 0.08 69.74 NEPHROPATHY | 3 0.03 69.77 NEPHROPATHY TOXIC | 1 0.01 69.78 NEPHROTIC SYNDROME | 4 0.04 69.82 NERVE INJURY | 1 0.01 69.83 NERVOUS SYSTEM DISORDER | 9 0.09 69.92 NERVOUS SYSTEM NEOPLASM BENIGN | 1 0.01 69.93 NERVOUSNESS | 14 0.14 70.07 NEURITIS | 1 0.01 70.08 NEUROGENIC BLADDER | 1 0.01 70.09 NEUROLEPTIC MALIGNANT SYNDROME | 5 0.05 70.14 NEUROMA | 1 0.01 70.15 NEUROPATHY | 6 0.06 70.21 NEUROPATHY PERIPHERAL | 7 0.07 70.28 NEUROSYPHILIS | 1 0.01 70.29 NEUTROPENIA | 14 0.14 70.43 NEUTROPENIC SEPSIS | 1 0.01 70.44 NEUTROPHIL COUNT DECREASED | 7 0.07 70.51 NEUTROPHIL COUNT INCREASED | 1 0.01 70.52 NEUTROPHIL PERCENTAGE INCREASED | 1 0.01 70.53 NEUTROPHILIA | 2 0.02 70.55 NIGHT CRAMPS | 1 0.01 70.56 NIGHT SWEATS | 6 0.06 70.62 NIGHTMARE | 6 0.06 70.68 NIPPLE DISORDER | 1 0.01 70.69 NIPPLE PAIN | 1 0.01 70.70 NO ADVERSE DRUG EFFECT | 2 0.02 70.72 NO ADVERSE EFFECT | 2 0.02 70.74 NOCTURIA | 4 0.04 70.78 NON-CARDIAC CHEST PAIN | 4 0.04 70.82 NON-HODGKIN'S LYMPHOMA | 2 0.02 70.84 NON-SMALL CELL LUNG CANCER | 1 0.01 70.85 NORMOCHROMIC NORMOCYTIC ANAEMIA | 1 0.01 70.86 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 1 0.01 70.87 NYSTAGMUS | 3 0.03 70.90 OBESITY | 1 0.01 70.91 OBSESSIVE-COMPULSIVE DISORDER | 3 0.03 70.94 OBSTRUCTION | 1 0.01 70.95 OBSTRUCTIVE AIRWAYS DISORDER | 1 0.01 70.96 OBSTRUCTIVE UROPATHY | 2 0.02 70.98 OCULAR ICTERUS | 1 0.01 70.99 OCULAR TOXICITY | 1 0.01 71.00 OCULAR VASCULAR DISORDER | 1 0.01 71.01 OCULOMUCOCUTANEOUS SYNDROME | 1 0.01 71.02 ODYNOPHAGIA | 2 0.02 71.04 OEDEMA | 14 0.14 71.18 OEDEMA PERIPHERAL | 55 0.55 71.73 OESOPHAGEAL DISORDER | 2 0.02 71.75 OESOPHAGEAL PERFORATION | 2 0.02 71.77 OESOPHAGEAL SPASM | 2 0.02 71.79 OESOPHAGEAL STENOSIS | 2 0.02 71.81 OESOPHAGEAL ULCER | 3 0.03 71.84 OESOPHAGEAL ULCER HAEMORRHAGE | 1 0.01 71.85 OESOPHAGITIS | 2 0.02 71.87 OESTROGEN DEFICIENCY | 1 0.01 71.88 OFF LABEL USE | 1 0.01 71.89 OLIGODIPSIA | 1 0.01 71.90 OLIGOMENORRHOEA | 3 0.03 71.93 OLIGURIA | 6 0.06 71.99 ONYCHOMYCOSIS | 2 0.02 72.01 ONYCHORRHEXIS | 1 0.01 72.02 OPEN ANGLE GLAUCOMA | 1 0.01 72.03 OPEN FRACTURE | 1 0.01 72.04 OPEN WOUND | 1 0.01 72.05 OPHTHALMOPLEGIA | 1 0.01 72.06 OPPORTUNISTIC INFECTION | 3 0.03 72.09 OPTIC DISC DISORDER | 1 0.01 72.10 OPTIC NERVE DISORDER | 1 0.01 72.11 OPTIC NEURITIS | 2 0.02 72.13 OPTIC NEUROPATHY | 1 0.01 72.14 ORAL CANDIDIASIS | 2 0.02 72.16 ORAL DISCOMFORT | 5 0.05 72.21 ORAL MUCOSAL BLISTERING | 3 0.03 72.24 ORAL PAIN | 4 0.04 72.28 ORAL PRURITUS | 1 0.01 72.29 ORGAN FAILURE | 1 0.01 72.30 OROPHARYNGEAL SWELLING | 4 0.04 72.34 ORTHOPNOEA | 1 0.01 72.35 ORTHOSTATIC HYPOTENSION | 9 0.09 72.44 OSTEITIS | 2 0.02 72.46 OSTEOARTHRITIS | 4 0.04 72.50 OSTEOLYSIS | 2 0.02 72.52 OSTEOMYELITIS | 3 0.03 72.55 OSTEOMYELITIS CHRONIC | 1 0.01 72.56 OSTEONECROSIS | 2 0.02 72.58 OSTEOPENIA | 2 0.02 72.60 OSTEOPOROSIS | 6 0.06 72.66 OTITIS MEDIA | 2 0.02 72.68 OTORRHOEA | 1 0.01 72.69 OVARIAN CANCER | 1 0.01 72.70 OVARIAN CANCER METASTATIC | 1 0.01 72.71 OVARIAN CYST | 2 0.02 72.73 OVARIAN DISORDER | 1 0.01 72.74 OVARIAN FAILURE | 1 0.01 72.75 OVERDOSE | 22 0.22 72.97 OXYGEN SATURATION DECREASED | 9 0.09 73.06 PAIN | 57 0.57 73.63 PAIN EXACERBATED | 3 0.03 73.66 PAIN IN EXTREMITY | 58 0.58 74.24 PAIN IN JAW | 5 0.05 74.29 PAIN OF SKIN | 2 0.02 74.31 PAINFUL RESPIRATION | 1 0.01 74.32 PALLOR | 4 0.04 74.36 PALMAR ERYTHEMA | 1 0.01 74.37 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 2 0.02 74.39 PALPABLE PURPURA | 1 0.01 74.40 PALPITATIONS | 28 0.28 74.68 PANCREATIC CARCINOMA | 1 0.01 74.69 PANCREATIC DISORDER | 1 0.01 74.70 PANCREATIC ENZYMES INCREASED | 1 0.01 74.71 PANCREATITIS | 15 0.15 74.86 PANCREATITIS ACUTE | 7 0.07 74.93 PANCREATITIS NECROTISING | 1 0.01 74.94 PANCYTOPENIA | 18 0.18 75.12 PANIC ATTACK | 4 0.04 75.16 PANIC DISORDER | 2 0.02 75.18 PANIC REACTION | 2 0.02 75.20 PAPILLARY THYROID CANCER | 2 0.02 75.22 PAPILLOEDEMA | 1 0.01 75.23 PARAESTHESIA | 24 0.24 75.47 PARAESTHESIA ORAL | 4 0.04 75.51 PARALYSIS | 3 0.03 75.54 PARANOIA | 5 0.05 75.59 PARAPROTEINAEMIA | 1 0.01 75.60 PARATHYROID DISORDER | 1 0.01 75.61 PARESIS | 1 0.01 75.62 PARKINSON'S DISEASE | 1 0.01 75.63 PARKINSONISM | 2 0.02 75.65 PARTIAL SEIZURES WITH SECONDARY GENER.. | 1 0.01 75.66 PCO2 DECREASED | 2 0.02 75.68 PELVIC FRACTURE | 2 0.02 75.70 PELVIC HAEMATOMA | 1 0.01 75.71 PELVIC MASS | 1 0.01 75.72 PELVIC NEOPLASM | 1 0.01 75.73 PELVIC ORGAN INJURY | 1 0.01 75.74 PELVIC PAIN | 2 0.02 75.76 PEPTIC ULCER | 2 0.02 75.78 PEPTIC ULCER HAEMORRHAGE | 1 0.01 75.79 PERFORMANCE STATUS DECREASED | 1 0.01 75.80 PERICARDIAL EFFUSION | 9 0.09 75.89 PERICARDIAL RUB | 1 0.01 75.90 PERICARDITIS | 2 0.02 75.92 PERICARDITIS CONSTRICTIVE | 1 0.01 75.93 PERIODONTAL DISEASE | 1 0.01 75.94 PERIODONTITIS | 1 0.01 75.95 PERIORBITAL OEDEMA | 1 0.01 75.96 PERIPHERAL CIRCULATORY FAILURE | 1 0.01 75.97 PERIPHERAL COLDNESS | 4 0.04 76.01 PERIPHERAL ISCHAEMIA | 3 0.03 76.04 PERIPHERAL OCCLUSIVE DISEASE | 2 0.02 76.06 PERIPHERAL VASCULAR DISORDER | 4 0.04 76.10 PERITONITIS | 2 0.02 76.12 PERITONSILLAR ABSCESS | 1 0.01 76.13 PERONEAL NERVE PALSY | 1 0.01 76.14 PERSECUTORY DELUSION | 1 0.01 76.15 PERSONALITY CHANGE | 2 0.02 76.17 PERSONALITY DISORDER | 2 0.02 76.19 PETECHIAE | 6 0.06 76.25 PETIT MAL EPILEPSY | 3 0.03 76.28 PHARMACEUTICAL PRODUCT COMPLAINT | 73 0.73 77.01 PHARMACEUTICAL PRODUCT COUNTERFEIT | 1 0.01 77.02 PHARYNGEAL ERYTHEMA | 1 0.01 77.03 PHARYNGEAL NEOPLASM | 1 0.01 77.04 PHARYNGITIS | 5 0.05 77.09 PHARYNGOLARYNGEAL PAIN | 14 0.14 77.23 PHARYNX DISCOMFORT | 2 0.02 77.25 PHLEBITIS | 4 0.04 77.29 PHLEBITIS SUPERFICIAL | 1 0.01 77.30 PHLEBOTHROMBOSIS | 1 0.01 77.31 PHOTOPHOBIA | 2 0.02 77.33 PHYSICAL ASSAULT | 1 0.01 77.34 PIGMENTATION DISORDER | 1 0.01 77.35 PILONIDAL CYST | 1 0.01 77.36 PITTING OEDEMA | 1 0.01 77.37 PITUITARY TUMOUR | 1 0.01 77.38 PITUITARY TUMOUR BENIGN | 1 0.01 77.39 PLACENTAL INSUFFICIENCY | 1 0.01 77.40 PLATELET COUNT ABNORMAL | 1 0.01 77.41 PLATELET COUNT DECREASED | 28 0.28 77.69 PLATELET COUNT INCREASED | 1 0.01 77.70 PLEURAL ADHESION | 1 0.01 77.71 PLEURAL DISORDER | 1 0.01 77.72 PLEURAL EFFUSION | 14 0.14 77.86 PLEURISY | 2 0.02 77.88 PLEURITIC PAIN | 1 0.01 77.89 PLEUROPERICARDITIS | 1 0.01 77.90 PNEUMOCOCCAL INFECTION | 1 0.01 77.91 PNEUMOCYSTIS CARINII INFECTION | 1 0.01 77.92 PNEUMOCYSTIS CARINII PNEUMONIA | 2 0.02 77.94 PNEUMONIA | 44 0.44 78.38 PNEUMONIA ASPIRATION | 7 0.07 78.45 PNEUMONIA BACTERIAL | 1 0.01 78.46 PNEUMONIA CYTOMEGALOVIRAL | 1 0.01 78.47 PNEUMONIA FUNGAL | 1 0.01 78.48 PNEUMONIA HAEMOPHILUS | 1 0.01 78.49 PNEUMONIA PNEUMOCOCCAL | 1 0.01 78.50 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 78.51 PNEUMONIA STAPHYLOCOCCAL | 1 0.01 78.52 PNEUMONITIS | 1 0.01 78.53 PNEUMOPERITONEUM | 1 0.01 78.54 PNEUMOTHORAX | 3 0.03 78.57 PO2 DECREASED | 2 0.02 78.59 POISONING | 2 0.02 78.61 POISONING DELIBERATE | 1 0.01 78.62 POLLAKIURIA | 17 0.17 78.79 POLYARTHRITIS | 1 0.01 78.80 POLYCYTHAEMIA | 2 0.02 78.82 POLYCYTHAEMIA VERA | 1 0.01 78.83 POLYDIPSIA | 1 0.01 78.84 POLYHYDRAMNIOS | 1 0.01 78.85 POLYMYALGIA RHEUMATICA | 1 0.01 78.86 POLYMYOSITIS | 3 0.03 78.89 POLYNEUROPATHY | 1 0.01 78.90 POLYSUBSTANCE ABUSE | 1 0.01 78.91 POLYURIA | 6 0.06 78.97 POOR PERIPHERAL CIRCULATION | 1 0.01 78.98 PORPHYRIA ACUTE | 1 0.01 78.99 POST COITAL BLEEDING | 1 0.01 79.00 POST LAMINECTOMY SYNDROME | 2 0.02 79.02 POST PROCEDURAL BILE LEAK | 1 0.01 79.03 POST PROCEDURAL COMPLICATION | 22 0.22 79.25 POST PROCEDURAL FISTULA | 1 0.01 79.26 POST PROCEDURAL HAEMATOMA | 1 0.01 79.27 POST PROCEDURAL HAEMORRHAGE | 4 0.04 79.31 POST PROCEDURAL PAIN | 4 0.04 79.35 POST THROMBOTIC SYNDROME | 2 0.02 79.37 POSTICTAL STATE | 1 0.01 79.38 POSTMENOPAUSAL HAEMORRHAGE | 1 0.01 79.39 POSTNASAL DRIP | 1 0.01 79.40 POSTOPERATIVE ILEUS | 1 0.01 79.41 POSTOPERATIVE INFECTION | 3 0.03 79.44 POSTOPERATIVE THORACIC PROCEDURE COMP.. | 1 0.01 79.45 POSTOPERATIVE THROMBOSIS | 1 0.01 79.46 POSTRENAL FAILURE | 2 0.02 79.48 PRE-ECLAMPSIA | 1 0.01 79.49 PRECURSOR B-LYMPHOBLASTIC LYMPHOMA RE.. | 1 0.01 79.50 PREGNANCY | 7 0.07 79.57 PREGNANCY AFTER POST COITAL CONTRACEP.. | 1 0.01 79.58 PREGNANCY ON ORAL CONTRACEPTIVE | 1 0.01 79.59 PREGNANCY WITH INJECTABLE CONTRACEPTIVE | 2 0.02 79.61 PREMATURE BABY | 19 0.19 79.80 PREMENSTRUAL SYNDROME | 1 0.01 79.81 PRESCRIBED OVERDOSE | 2 0.02 79.83 PROCEDURAL COMPLICATION | 2 0.02 79.85 PROCEDURAL HYPOTENSION | 2 0.02 79.87 PROCTALGIA | 1 0.01 79.88 PRODUCTIVE COUGH | 3 0.03 79.91 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 2 0.02 79.93 PROSTATE CANCER | 3 0.03 79.96 PROSTATE TENDERNESS | 1 0.01 79.97 PROSTATECTOMY | 2 0.02 79.99 PROSTATIC DISORDER | 3 0.03 80.02 PROSTATIC SPECIFIC ANTIGEN INCREASED | 1 0.01 80.03 PROTEIN S DEFICIENCY | 1 0.01 80.04 PROTEIN TOTAL DECREASED | 2 0.02 80.06 PROTEIN URINE PRESENT | 2 0.02 80.08 PROTEINURIA | 4 0.04 80.12 PROTHROMBIN TIME | 1 0.01 80.13 PROTHROMBIN TIME PROLONGED | 9 0.09 80.22 PROTHROMBIN TIME SHORTENED | 2 0.02 80.24 PRURITUS | 37 0.37 80.61 PRURITUS GENERALISED | 3 0.03 80.64 PSEUDODEMENTIA | 2 0.02 80.66 PSORIASIS | 7 0.07 80.73 PSORIATIC ARTHROPATHY | 1 0.01 80.74 PSYCHIATRIC SYMPTOM | 5 0.05 80.79 PSYCHOMOTOR HYPERACTIVITY | 1 0.01 80.80 PSYCHOMOTOR RETARDATION | 1 0.01 80.81 PSYCHOTIC DISORDER | 8 0.08 80.89 PUBIC RAMI FRACTURE | 1 0.01 80.90 PULMONARY ARTERY ATRESIA | 1 0.01 80.91 PULMONARY ARTERY THROMBOSIS | 1 0.01 80.92 PULMONARY CALCIFICATION | 1 0.01 80.93 PULMONARY CONGESTION | 5 0.05 80.98 PULMONARY EMBOLISM | 11 0.11 81.09 PULMONARY FIBROSIS | 9 0.09 81.18 PULMONARY FUNCTION TEST ABNORMAL | 1 0.01 81.19 PULMONARY HYPERTENSION | 7 0.07 81.26 PULMONARY HYPOPLASIA | 1 0.01 81.27 PULMONARY OEDEMA | 20 0.20 81.47 PULMONARY THROMBOSIS | 1 0.01 81.48 PULMONARY TOXICITY | 1 0.01 81.49 PULMONARY VALVE INCOMPETENCE | 1 0.01 81.50 PULSE ABNORMAL | 1 0.01 81.51 PULSE ABSENT | 3 0.03 81.54 PURPURA | 4 0.04 81.58 PURULENT DISCHARGE | 1 0.01 81.59 PYELONEPHRITIS | 3 0.03 81.62 PYODERMA | 1 0.01 81.63 PYOTHORAX | 1 0.01 81.64 PYREXIA | 101 1.01 82.65 PYURIA | 1 0.01 82.66 RADIATION PNEUMONITIS | 1 0.01 82.67 RADICULITIS | 1 0.01 82.68 RADICULOPATHY | 5 0.05 82.73 RADIUS FRACTURE | 1 0.01 82.74 RASH | 45 0.45 83.19 RASH ERYTHEMATOUS | 8 0.08 83.27 RASH GENERALISED | 8 0.08 83.35 RASH MACULAR | 5 0.05 83.40 RASH MACULO-PAPULAR | 10 0.10 83.50 RASH PAPULAR | 5 0.05 83.55 RASH PRURITIC | 11 0.11 83.66 RASH PUSTULAR | 2 0.02 83.68 RASH SCALY | 1 0.01 83.69 RAYNAUD'S PHENOMENON | 1 0.01 83.70 REBOUND EFFECT | 1 0.01 83.71 RECTAL HAEMORRHAGE | 19 0.19 83.90 RECTAL POLYP | 1 0.01 83.91 RECTAL ULCER | 1 0.01 83.92 RECTOCELE | 1 0.01 83.93 RECURRING SKIN BOILS | 1 0.01 83.94 RED BLOOD CELL COUNT DECREASED | 3 0.03 83.97 RED BLOOD CELL COUNT INCREASED | 1 0.01 83.98 RED BLOOD CELL SEDIMENTATION RATE INC.. | 3 0.03 84.01 RED BLOOD CELLS URINE | 1 0.01 84.02 RED BLOOD CELLS URINE POSITIVE | 1 0.01 84.03 RED CELL DISTRIBUTION WIDTH INCREASED | 1 0.01 84.04 REFLEX SYMPATHETIC DYSTROPHY | 2 0.02 84.06 REFLUX OESOPHAGITIS | 5 0.05 84.11 REFRACTORY ANAEMIA WITH RINGED SIDERO.. | 1 0.01 84.12 REFUSAL OF TREATMENT BY PATIENT | 6 0.06 84.18 REFUSAL OF TREATMENT BY RELATIVE | 1 0.01 84.19 RENAL AMYLOIDOSIS | 1 0.01 84.20 RENAL ARTERY STENOSIS | 1 0.01 84.21 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 2 0.02 84.23 RENAL COLIC | 1 0.01 84.24 RENAL CYST | 4 0.04 84.28 RENAL DISORDER | 10 0.10 84.38 RENAL FAILURE | 38 0.38 84.76 RENAL FAILURE ACUTE | 43 0.43 85.19 RENAL FAILURE CHRONIC | 3 0.03 85.22 RENAL IMPAIRMENT | 16 0.16 85.38 RENAL INJURY | 1 0.01 85.39 RENAL PAIN | 3 0.03 85.42 RENAL TRANSPLANT | 1 0.01 85.43 RENAL TUBULAR ACIDOSIS | 1 0.01 85.44 RENAL TUBULAR DISORDER | 2 0.02 85.46 RENAL TUBULAR NECROSIS | 4 0.04 85.50 RENAL TUMOUR EXCISION | 1 0.01 85.51 RESPIRATORY ALKALOSIS | 1 0.01 85.52 RESPIRATORY ARREST | 8 0.08 85.60 RESPIRATORY DEPRESSION | 3 0.03 85.63 RESPIRATORY DISORDER | 5 0.05 85.68 RESPIRATORY DISTRESS | 12 0.12 85.80 RESPIRATORY FAILURE | 10 0.10 85.90 RESPIRATORY RATE DECREASED | 3 0.03 85.93 RESPIRATORY RATE INCREASED | 7 0.07 86.00 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 1 0.01 86.01 RESPIRATORY TRACT INFECTION | 3 0.03 86.04 RESPIRATORY TRACT INFECTION VIRAL | 1 0.01 86.05 RESTLESS LEGS SYNDROME | 1 0.01 86.06 RESTLESSNESS | 5 0.05 86.11 RESTRICTIVE PULMONARY DISEASE | 1 0.01 86.12 RETCHING | 3 0.03 86.15 RETICULOCYTE COUNT INCREASED | 2 0.02 86.17 RETINAL DETACHMENT | 4 0.04 86.21 RETINAL HAEMORRHAGE | 1 0.01 86.22 RETINAL ISCHAEMIA | 1 0.01 86.23 RETINAL OEDEMA | 2 0.02 86.25 RETINAL PIGMENTATION | 1 0.01 86.26 RETINAL VEIN OCCLUSION | 1 0.01 86.27 RETINAL VEIN THROMBOSIS | 1 0.01 86.28 RETINITIS PIGMENTOSA | 1 0.01 86.29 RETINOGRAM ABNORMAL | 1 0.01 86.30 RETINOPATHY | 1 0.01 86.31 RETROGRADE AMNESIA | 1 0.01 86.32 RETROGRADE EJACULATION | 1 0.01 86.33 RETROPERITONEAL HAEMORRHAGE | 2 0.02 86.35 RHABDOMYOLYSIS | 41 0.41 86.76 RHEUMATIC FEVER | 1 0.01 86.77 RHEUMATOID ARTHRITIS | 5 0.05 86.82 RHINITIS | 2 0.02 86.84 RHINITIS ALLERGIC | 2 0.02 86.86 RHINITIS SEASONAL | 1 0.01 86.87 RHINORRHOEA | 8 0.08 86.95 RIB FRACTURE | 2 0.02 86.97 RIGHT VENTRICULAR FAILURE | 4 0.04 87.01 ROAD TRAFFIC ACCIDENT | 14 0.14 87.15 ROTATOR CUFF SYNDROME | 6 0.06 87.21 RUPTURED ECTOPIC PREGNANCY | 1 0.01 87.22 SACROILIITIS | 1 0.01 87.23 SALIVARY HYPERSECRETION | 3 0.03 87.26 SALPINGITIS | 1 0.01 87.27 SARCOIDOSIS | 1 0.01 87.28 SCAB | 1 0.01 87.29 SCAR | 7 0.07 87.36 SCHIZOPHRENIA, PARANOID TYPE | 1 0.01 87.37 SCIATIC NERVE NEUROPATHY | 1 0.01 87.38 SCIATICA | 3 0.03 87.41 SCINTILLATING SCOTOMA | 1 0.01 87.42 SCLERAL HAEMORRHAGE | 1 0.01 87.43 SCLERITIS | 1 0.01 87.44 SCOTOMA | 1 0.01 87.45 SCRATCH | 1 0.01 87.46 SCREAMING | 2 0.02 87.48 SEBACEOUS GLAND DISORDER | 1 0.01 87.49 SEDATION | 4 0.04 87.53 SELF MUTILATION | 1 0.01 87.54 SELF-MEDICATION | 3 0.03 87.57 SENSATION OF BLOCK IN EAR | 1 0.01 87.58 SENSATION OF FOREIGN BODY | 3 0.03 87.61 SENSATION OF HEAVINESS | 3 0.03 87.64 SENSATION OF PRESSURE | 3 0.03 87.67 SENSATION OF PRESSURE IN EAR | 1 0.01 87.68 SENSORY DISTURBANCE | 2 0.02 87.70 SENSORY INTEGRATIVE DYSFUNCTION | 1 0.01 87.71 SENSORY LOSS | 4 0.04 87.75 SEPSIS | 30 0.30 88.05 SEPSIS NEONATAL | 9 0.09 88.14 SEPTIC SHOCK | 5 0.05 88.19 SEQUESTRECTOMY | 1 0.01 88.20 SEROTONIN SYNDROME | 5 0.05 88.25 SERRATIA INFECTION | 1 0.01 88.26 SERUM FERRITIN INCREASED | 1 0.01 88.27 SERUM SICKNESS | 1 0.01 88.28 SEXUAL DYSFUNCTION | 4 0.04 88.32 SHOCK | 10 0.10 88.42 SHOCK HYPOGLYCAEMIC | 1 0.01 88.43 SIALOADENITIS | 1 0.01 88.44 SILENT MYOCARDIAL INFARCTION | 1 0.01 88.45 SIMPLE PARTIAL SEIZURES | 1 0.01 88.46 SINUS ARRHYTHMIA | 1 0.01 88.47 SINUS BRADYCARDIA | 4 0.04 88.51 SINUS CONGESTION | 1 0.01 88.52 SINUS DISORDER | 2 0.02 88.54 SINUS PAIN | 1 0.01 88.55 SINUS TACHYCARDIA | 7 0.07 88.62 SINUSITIS | 11 0.11 88.73 SJOGREN'S SYNDROME | 1 0.01 88.74 SKIN ATROPHY | 1 0.01 88.75 SKIN DESQUAMATION | 5 0.05 88.80 SKIN DISCOLOURATION | 5 0.05 88.85 SKIN DISORDER | 10 0.10 88.95 SKIN FISSURES | 1 0.01 88.96 SKIN HYPERPIGMENTATION | 1 0.01 88.97 SKIN INFLAMMATION | 2 0.02 88.99 SKIN INJURY | 1 0.01 89.00 SKIN IRRITATION | 4 0.04 89.04 SKIN LACERATION | 3 0.03 89.07 SKIN LESION | 2 0.02 89.09 SKIN NECROSIS | 4 0.04 89.13 SKIN ODOUR ABNORMAL | 1 0.01 89.14 SKIN PAPILLOMA | 1 0.01 89.15 SKIN REACTION | 3 0.03 89.18 SKIN STRIAE | 1 0.01 89.19 SKIN SWELLING | 1 0.01 89.20 SKIN TEST POSITIVE | 1 0.01 89.21 SKIN ULCER | 2 0.02 89.23 SKIN ULCER HAEMORRHAGE | 1 0.01 89.24 SLE ARTHRITIS | 1 0.01 89.25 SLEEP APNOEA SYNDROME | 12 0.12 89.37 SLEEP ATTACKS | 1 0.01 89.38 SLEEP DISORDER | 8 0.08 89.46 SLEEP PHASE RHYTHM DISTURBANCE | 1 0.01 89.47 SLEEP TALKING | 1 0.01 89.48 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 1 0.01 89.49 SMALL INTESTINAL HAEMORRHAGE | 1 0.01 89.50 SMALL INTESTINAL OBSTRUCTION | 4 0.04 89.54 SMOKER | 1 0.01 89.55 SNEEZING | 2 0.02 89.57 SNORING | 2 0.02 89.59 SOCIAL AVOIDANT BEHAVIOUR | 4 0.04 89.63 SOCIAL FEAR | 1 0.01 89.64 SOCIAL PHOBIA | 2 0.02 89.66 SOCIAL PROBLEM | 1 0.01 89.67 SODIUM RETENTION | 1 0.01 89.68 SOFT TISSUE INFECTION | 2 0.02 89.70 SOMNOLENCE | 33 0.33 90.03 SPEECH DISORDER | 14 0.14 90.17 SPINAL COLUMN STENOSIS | 3 0.03 90.20 SPINAL COMPRESSION FRACTURE | 3 0.03 90.23 SPINAL CORD PARALYSIS | 1 0.01 90.24 SPINAL DISORDER | 2 0.02 90.26 SPINAL FRACTURE | 2 0.02 90.28 SPINAL OSTEOARTHRITIS | 2 0.02 90.30 SPLENIC CYST | 1 0.01 90.31 SPLENIC INJURY | 2 0.02 90.33 SPLENOMEGALY | 6 0.06 90.39 SPONDYLOSIS | 2 0.02 90.41 SPONTANEOUS PENILE ERECTION | 1 0.01 90.42 SPUTUM ABNORMAL | 1 0.01 90.43 SPUTUM CULTURE POSITIVE | 1 0.01 90.44 SPUTUM DISCOLOURED | 2 0.02 90.46 SQUAMOUS CELL CARCINOMA | 3 0.03 90.49 STAPHYLOCOCCAL INFECTION | 8 0.08 90.57 STAPHYLOCOCCAL SEPSIS | 1 0.01 90.58 STARING | 1 0.01 90.59 STATUS EPILEPTICUS | 4 0.04 90.63 STEM CELL TRANSPLANT | 2 0.02 90.65 STENOTROPHOMONAS INFECTION | 1 0.01 90.66 STENT OCCLUSION | 4 0.04 90.70 STENT PLACEMENT | 1 0.01 90.71 STEVENS-JOHNSON SYNDROME | 5 0.05 90.76 STILLBIRTH | 1 0.01 90.77 STOMACH DISCOMFORT | 10 0.10 90.87 STOMATITIS | 6 0.06 90.93 STRABISMUS | 1 0.01 90.94 STREPTOCOCCAL INFECTION | 1 0.01 90.95 STRESS INCONTINENCE | 2 0.02 90.97 STRESS SYMPTOMS | 9 0.09 91.06 STRIDOR | 1 0.01 91.07 SUBARACHNOID HAEMORRHAGE | 1 0.01 91.08 SUBCUTANEOUS ABSCESS | 1 0.01 91.09 SUBDURAL HAEMATOMA | 3 0.03 91.12 SUBILEUS | 4 0.04 91.16 SUDDEN CARDIAC DEATH | 2 0.02 91.18 SUDDEN DEATH | 4 0.04 91.22 SUDDEN ONSET OF SLEEP | 1 0.01 91.23 SUFFOCATION FEELING | 1 0.01 91.24 SUICIDAL IDEATION | 28 0.28 91.52 SUICIDE ATTEMPT | 5 0.05 91.57 SUPRAVENTRICULAR EXTRASYSTOLES | 1 0.01 91.58 SUPRAVENTRICULAR TACHYCARDIA | 6 0.06 91.64 SURGERY | 4 0.04 91.68 SURGICAL PROCEDURE REPEATED | 3 0.03 91.71 SWELLING | 16 0.16 91.87 SWELLING FACE | 9 0.09 91.96 SWOLLEN TONGUE | 8 0.08 92.04 SYNCOPE | 16 0.16 92.20 SYNCOPE VASOVAGAL | 4 0.04 92.24 SYPHILIS | 1 0.01 92.25 SYSTEMIC LUPUS ERYTHEMATOSUS | 2 0.02 92.27 SYSTEMIC LUPUS ERYTHEMATOSUS RASH | 1 0.01 92.28 T-CELL LYMPHOMA | 1 0.01 92.29 TACHYARRHYTHMIA | 1 0.01 92.30 TACHYCARDIA | 21 0.21 92.51 TACHYCARDIA FOETAL | 1 0.01 92.52 TARDIVE DYSKINESIA | 1 0.01 92.53 TEARFULNESS | 1 0.01 92.54 TELANGIECTASIA | 1 0.01 92.55 TEMPOROMANDIBULAR JOINT SYNDROME | 1 0.01 92.56 TENDERNESS | 3 0.03 92.59 TENDON DISORDER | 1 0.01 92.60 TENDONITIS | 4 0.04 92.64 TENOSYNOVITIS | 1 0.01 92.65 TENSION | 1 0.01 92.66 TENSION HEADACHE | 2 0.02 92.68 TETANY | 1 0.01 92.69 THALAMUS HAEMORRHAGE | 1 0.01 92.70 THERAPEUTIC AGENT TOXICITY | 2 0.02 92.72 THERAPEUTIC PROCEDURE | 1 0.01 92.73 THERAPEUTIC RESPONSE DECREASED | 7 0.07 92.80 THERAPY NON-RESPONDER | 2 0.02 92.82 THINKING ABNORMAL | 1 0.01 92.83 THORACIC VERTEBRAL FRACTURE | 1 0.01 92.84 THROAT IRRITATION | 5 0.05 92.89 THROAT TIGHTNESS | 3 0.03 92.92 THROMBOCYTHAEMIA | 2 0.02 92.94 THROMBOCYTOPENIA | 26 0.26 93.20 THROMBOCYTOPENIC PURPURA | 1 0.01 93.21 THROMBOPHLEBITIS | 1 0.01 93.22 THROMBOSIS | 10 0.10 93.32 THYROID CANCER METASTATIC | 3 0.03 93.35 THYROID DISORDER | 3 0.03 93.38 THYROID GLAND CANCER | 1 0.01 93.39 TINNITUS | 14 0.14 93.53 TOE AMPUTATION | 1 0.01 93.54 TOE DEFORMITY | 2 0.02 93.56 TONGUE BLISTERING | 1 0.01 93.57 TONGUE COATED | 2 0.02 93.59 TONGUE DISCOLOURATION | 1 0.01 93.60 TONGUE PARALYSIS | 1 0.01 93.61 TONGUE ULCERATION | 1 0.01 93.62 TONIC CLONIC MOVEMENTS | 1 0.01 93.63 TONSIL CANCER | 1 0.01 93.64 TONSILLECTOMY | 1 0.01 93.65 TONSILLITIS | 1 0.01 93.66 TOOTH DISCOLOURATION | 1 0.01 93.67 TOOTH DISORDER | 3 0.03 93.70 TOOTH EXTRACTION | 4 0.04 93.74 TOOTH IMPACTED | 1 0.01 93.75 TOOTH INJURY | 1 0.01 93.76 TOOTHACHE | 1 0.01 93.77 TORSADE DE POINTES | 3 0.03 93.80 TOURETTE'S DISORDER | 1 0.01 93.81 TOXIC EPIDERMAL NECROLYSIS | 4 0.04 93.85 TOXIC INDUCED ENCEPHALOPATHY | 1 0.01 93.86 TOXIC SHOCK SYNDROME | 1 0.01 93.87 TOXIC SKIN ERUPTION | 4 0.04 93.91 TRANSAMINASES DECREASED | 1 0.01 93.92 TRANSAMINASES INCREASED | 7 0.07 93.99 TRANSIENT ISCHAEMIC ATTACK | 16 0.16 94.15 TRANSMISSION OF DRUG VIA SEMEN | 2 0.02 94.17 TRANSPLANT | 1 0.01 94.18 TRAUMATIC BRAIN INJURY | 1 0.01 94.19 TREATMENT NONCOMPLIANCE | 19 0.19 94.38 TREMOR | 31 0.31 94.69 TREMOR NEONATAL | 1 0.01 94.70 TRICHORRHEXIS | 1 0.01 94.71 TRICUSPID VALVE INCOMPETENCE | 10 0.10 94.81 TRIGGER FINGER | 2 0.02 94.83 TRIPLE VESSEL BYPASS GRAFT | 1 0.01 94.84 TRISOMY 21 | 1 0.01 94.85 TUBERCULOSIS | 2 0.02 94.87 TUMOUR HAEMORRHAGE | 1 0.01 94.88 TUMOUR LYSIS SYNDROME | 1 0.01 94.89 TUMOUR MARKER INCREASED | 1 0.01 94.90 TWIN PREGNANCY | 1 0.01 94.91 TYMPANIC MEMBRANE HYPERAEMIA | 2 0.02 94.93 ULCER | 5 0.05 94.98 ULCER HAEMORRHAGE | 1 0.01 94.99 ULNA FRACTURE | 1 0.01 95.00 UMBILICAL CORD ABNORMALITY | 1 0.01 95.01 UMBILICAL CORD VASCULAR DISORDER | 1 0.01 95.02 UMBILICAL HERNIA | 2 0.02 95.04 UNEVALUABLE EVENT | 5 0.05 95.09 UNEXPECTED THERAPEUTIC DRUG EFFECT | 1 0.01 95.10 UNINTENDED PREGNANCY | 3 0.03 95.13 UPPER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 95.14 UPPER LIMB FRACTURE | 3 0.03 95.17 UPPER RESPIRATORY TRACT INFECTION | 7 0.07 95.24 URETERIC OBSTRUCTION | 1 0.01 95.25 URETHRAL DISORDER | 1 0.01 95.26 URETHRITIS | 1 0.01 95.27 URGE INCONTINENCE | 1 0.01 95.28 URINARY BLADDER HAEMORRHAGE | 1 0.01 95.29 URINARY HESITATION | 1 0.01 95.30 URINARY INCONTINENCE | 9 0.09 95.39 URINARY RETENTION | 6 0.06 95.45 URINARY SEDIMENT PRESENT | 2 0.02 95.47 URINARY TRACT INFECTION | 18 0.18 95.65 URINE AMYLASE INCREASED | 1 0.01 95.66 URINE ANALYSIS ABNORMAL | 2 0.02 95.68 URINE FLOW DECREASED | 1 0.01 95.69 URINE LEUKOCYTE ESTERASE POSITIVE | 1 0.01 95.70 URINE ODOUR ABNORMAL | 2 0.02 95.72 URINE OUTPUT DECREASED | 4 0.04 95.76 UROSEPSIS | 5 0.05 95.81 URTICARIA | 18 0.18 95.99 UTERINE DILATION AND CURETTAGE | 2 0.02 96.01 UTERINE DISORDER | 2 0.02 96.03 UTERINE LEIOMYOMA | 2 0.02 96.05 UTERINE MASS | 1 0.01 96.06 UVEITIS | 1 0.01 96.07 VAGINAL BURNING SENSATION | 1 0.01 96.08 VAGINAL CANCER | 1 0.01 96.09 VAGINAL DISORDER | 1 0.01 96.10 VAGINAL HAEMORRHAGE | 7 0.07 96.17 VAGINAL HYSTERECTOMY | 1 0.01 96.18 VAGINAL MYCOSIS | 1 0.01 96.19 VAGINAL PROLAPSE | 1 0.01 96.20 VARICOSE VEIN | 4 0.04 96.24 VARICOSE VEIN OPERATION | 1 0.01 96.25 VARICOSE VEINS PELVIC | 1 0.01 96.26 VASCULAR BYPASS GRAFT | 1 0.01 96.27 VASCULAR CALCIFICATION | 2 0.02 96.29 VASCULAR GRAFT OCCLUSION | 2 0.02 96.31 VASCULAR INSUFFICIENCY | 1 0.01 96.32 VASCULAR OCCLUSION | 1 0.01 96.33 VASCULAR PURPURA | 1 0.01 96.34 VASCULITIC RASH | 1 0.01 96.35 VASCULITIS | 3 0.03 96.38 VASCULITIS CEREBRAL | 1 0.01 96.39 VASODILATATION | 1 0.01 96.40 VASOSPASM | 1 0.01 96.41 VEIN DISORDER | 3 0.03 96.44 VENOOCCLUSIVE DISEASE | 1 0.01 96.45 VENOUS THROMBOSIS LIMB | 1 0.01 96.46 VENTRICULAR ARRHYTHMIA | 1 0.01 96.47 VENTRICULAR DYSFUNCTION | 4 0.04 96.51 VENTRICULAR EXTRASYSTOLES | 6 0.06 96.57 VENTRICULAR FAILURE | 1 0.01 96.58 VENTRICULAR FIBRILLATION | 6 0.06 96.64 VENTRICULAR HYPERTROPHY | 8 0.08 96.72 VENTRICULAR HYPOKINESIA | 2 0.02 96.74 VENTRICULAR TACHYCARDIA | 7 0.07 96.81 VERTIGO | 7 0.07 96.88 VERTIGO POSITIONAL | 1 0.01 96.89 VERY LOW DENSITY LIPOPROTEIN DECREASED | 1 0.01 96.90 VESTIBULAR DISORDER | 1 0.01 96.91 VICTIM OF CRIME | 1 0.01 96.92 VIRAEMIA | 1 0.01 96.93 VIRAL INFECTION | 4 0.04 96.97 VIRAL UPPER RESPIRATORY TRACT INFECTION | 2 0.02 96.99 VISION BLURRED | 36 0.36 97.35 VISUAL ACUITY REDUCED | 15 0.15 97.50 VISUAL DISTURBANCE | 16 0.16 97.66 VISUAL FIELD DEFECT | 1 0.01 97.67 VITAMIN B12 DEFICIENCY | 3 0.03 97.70 VITAMIN D INCREASED | 1 0.01 97.71 VITAMIN K | 1 0.01 97.72 VITH NERVE PARALYSIS | 1 0.01 97.73 VITREOUS DETACHMENT | 1 0.01 97.74 VITREOUS OPACITIES | 1 0.01 97.75 VOMITING | 68 0.68 98.43 VULVAL CANCER | 1 0.01 98.44 VULVOVAGINAL DISCOMFORT | 1 0.01 98.45 WALKING AID USER | 2 0.02 98.47 WEIGHT DECREASED | 48 0.48 98.95 WEIGHT INCREASED | 45 0.45 99.40 WEIGHT LOSS POOR | 1 0.01 99.41 WHEEZING | 8 0.08 99.49 WHITE BLOOD CELL COUNT DECREASED | 18 0.18 99.67 WHITE BLOOD CELL COUNT INCREASED | 19 0.19 99.86 WHITE BLOOD CELLS URINE | 1 0.01 99.87 WHITE BLOOD CELLS URINE POSITIVE | 2 0.02 99.89 WOUND | 2 0.02 99.91 WOUND DEHISCENCE | 1 0.01 99.92 WOUND INFECTION | 1 0.01 99.93 WOUND INFECTION STAPHYLOCOCCAL | 1 0.01 99.94 WOUND SECRETION | 1 0.01 99.95 WRIST FRACTURE | 3 0.03 99.98 X-RAY GASTROINTESTINAL TRACT ABNORMAL | 1 0.01 99.99 ZYGOMYCOSIS | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015